,drug_name,section_name,gpt_output
0,KYPROLIS,adverse reactions,"Cardiac Toxicities, Acute Renal Failure, Tumor Lysis Syndrome, Pulmonary Toxicity, Pulmonary Hypertension, Dyspnea, Hypertension, Venous Thrombosis, Infusion Reactions, Thrombocytopenia, Hepatic Toxicity, Hepatic Failure, Thrombotic Thrombocytopenic Purpura, Hemolytic Uremic Syndrome, Posterior Reversible Encephalopathy Syndrome (PRES), anemia, fatigue, nausea, pyrexia, decreased platelets, diarrhea, decreased lymphocyte, headache, decreased hemoglobin, cough, edema peripheral, decreased absolute neutrophil count, decreased phosphorus, neutropenia, decreased total white blood cell count, muscle spasm, upper respiratory tract infection, hypokalemia, pneumonia, respiratory tract infection, pulmonary embolism, constipation, asthenia, nasopharyngitis, bronchitis, hypocalcemia, hyperglycemia, muscle spasms, peripheral neuropathies NEC, insomnia, rash, embolic and thrombotic events, venous, febrile neutropenia, lymphopenia, cardiac arrest, cardiac failure, cardiac failure congestive, myocardial infarction, myocardial ischemia, cataract, vision blurred, abdominal pain, abdominal pain upper, dyspepsia, toothache, chills, infusion site reaction, multi-organ failure, pain, influenza, sepsis, urinary tract infection, viral infection, dehydration, hyperkalemia, hyperuricemia, hypoalbuminemia, hyponatremia, muscular weakness, myalgia, hypoesthesia, paresthesia, deafness, anxiety, delirium, renal failure, renal failure acute, renal impairment, dysphonia, epistaxis, oropharyngeal pain, pulmonary edema, erythema, hyperhidrosis, pruritus, deep vein thrombosis, hypotension, decreased appetite, hypercalcemia, back pain, arthralgia, pain in extremity, musculoskeletal pain, headache, dizziness, insomnia, dyspnea, epistaxis, renal failure, hypertension, dehydration, thrombotic thrombocytopenic purpura/hemolytic uremic syndrome (TTP/HUS), tumor lysis syndrome, posterior reversible encephalopathy syndrome (PRES), death."
1,KYPROLIS,warnings and precautions,"cardiac failure, myocardial infarction, fatal outcome, myocardial ischemia, Acute Renal Failure, Tumor Lysis Syndrome, Acute Respiratory Distress Syndrome, acute respiratory failure, acute diffuse infiltrative pulmonary disease, Pulmonary Hypertension, Dyspnea, Hypertension, hypertensive crisis, Venous Thrombosis, Infusion Reactions, Thrombocytopenia, Hepatic Toxicity, Hepatic Failure, Thrombotic thrombocytopenic purpura, hemolytic uremic syndrome, Posterior reversible encephalopathy syndrome, Embryo-fetal Toxicity, death"
2,MULTAQ,adverse reactions,"New or worsening heart failure, Liver Injury, Pulmonary toxicity, Hypokalemia, Hypomagnesemia, QT prolongation, Diarrhea, Nausea, Abdominal pain, Vomiting, Asthenia, Bradycardia, Rashes, Pruritus, Eczema, Dermatitis, Dermatitis allergic, Photosensitivity reaction, Dysgeusia, Early increases in creatinine, QTc prolonged, Atrial flutter with 1:1 atrioventricular conduction, Interstitial lung disease, Pneumonitis, Pulmonary fibrosis, Anaphylactic reactions, Angioedema, Vasculitis, Leukocytoclastic vasculitis"
3,MULTAQ,boxed warnings,"death, stroke, heart failure, hospitalization for heart failure, symptomatic heart failure, recent decompensation, NYHA Class IV heart failure, permanent atrial fibrillation"
4,MULTAQ,warnings and precautions,"cardiac rhythm abnormalities, atrial fibrillation (AF), liver injury, hepatic injury, pulmonary toxicity, hypokalemia, hypomagnesemia, renal impairment, teratogen, cardiovascular death, heart failure, stroke, new onset heart failure, worsening heart failure, hepatocellular liver injury, acute liver failure, interstitial lung disease, pneumonitis, pulmonary fibrosis, dyspnea, non-productive cough, QT interval prolongation, pre-renal azotemia, acute renal failure, serum creatinine increase, fetal harm, death"
5,JUBLIA,adverse reactions,"ingrown toenails, application site dermatitis, application site vesicles, application site pain"
6,TEFLARO,adverse reactions,"Hypersensitivity Reactions, Clostridium difficile-Associated diarrhea, Direct Coombs' Test Seroconversion, diarrhea, nausea, rash, hypersensitivity, anemia, eosinophilia, neutropenia, thrombocytopenia, bradycardia, palpitations, abdominal pain, pyrexia, hepatitis, anaphylaxis, Clostridium difficile colitis, hyperglycemia, hyperkalemia, dizziness, convulsion, renal failure, urticaria, agranulocytosis, constipation, vomiting, increased transaminases, hypokalemia, phlebitis"
7,TEFLARO,warnings and precautions,"Serious hypersensitivity reactions, anaphylactic reactions, Clostridium difficile-associated diarrhea (CDAD), fatal colitis, Direct Coombs' test seroconversion, drug-induced hemolytic anemia, development of drug-resistant bacteria, death"
8,DATSCAN,adverse reactions,"hypersensitivity, injection site reactions, headache, nausea, vertigo, dry mouth, dizziness, rash, pruritis, injection site pain"
9,DATSCAN,warnings and precautions,"hypersensitivity reactions, anaphylactic, skin erythema, pruritis, thyroid neoplasia"
10,TIVICAY,adverse reactions,"Hypersensitivity reactions, Effects on serum liver biochemistries, Fat Redistribution, Immune Reconstitution Syndrome, insomnia, fatigue, headache, Treatment-emergent Adverse Drug Reactions, nausea, diarrhea, rash (includes rash generalized, rash macular, rash maculo-papular, rash pruritic, drug eruption), abnormal dreams, dizziness, vertigo, abdominal pain, abdominal discomfort, flatulence, upper abdominal pain, vomiting, hepatitis, myositis, suicidal ideation, suicidal attempt, suicidal behavior, suicidal completion, renal impairment, pruritus, laboratory abnormalities, ALT abnormalities, AST abnormalities, creatine kinase abnormalities, hyperglycemia, lipase abnormalities, total neutrophils abnormalities, cholesterol changes, HDL cholesterol changes, LDL cholesterol changes, triglycerides changes, elevated total bilirubin, elevated lipase, changes in mean serum creatinine"
11,TIVICAY,warnings and precautions,"hypersensitivity reactions, rash, constitutional findings, organ dysfunction, liver injury, transaminase elevations, hepatotoxicity, redistribution/accumulation of body fat, central obesity, dorsocervical fat enlargement (buffalo hump), peripheral wasting, facial wasting, breast enlargement, cushingoid appearance, immune reconstitution syndrome, inflammatory response, Mycobacterium avium infection, cytomegalovirus, Pneumocystis jirovecii pneumonia (PCP), tuberculosis, autoimmune disorders, Graves' disease, polymyositis, Guillain-Barre syndrome, hepatitis, eosinophilia, angioedema, difficulty breathing, hepatitis B reactivation, severe rash, fever, general malaise, fatigue, muscle or joint aches, blisters, peeling of the skin, oral blisters, lesions, conjunctivitis, facial edema, death"
12,TAFINLAR,adverse reactions,"New Primary Malignancies, Tumor Promotion in BRAF Wild-Type Melanoma, Hemorrhage, Venous Thromboembolism, Cardiomyopathy, Ocular Toxicities, Serious Febrile Reactions, Serious Skin Toxicity, Hyperglycemia, Glucose-6-Phosphate Dehydrogenase Deficiency, hyperkeratosis, headache, pyrexia, arthralgia, papilloma, alopecia, palmar-plantar erythrodysesthesia syndrome, chills, fatigue, rash, nausea, vomiting, diarrhea, abdominal pain, peripheral edema, cough, night sweats, decreased appetite, constipation, myalgia, back pain, myalgia, cuSCC, cough, constipation, nasopharyngitis, hypophosphatemia, increased alkaline phosphatase, hyponatremia, pancreatitis, hypersensitivity manifesting as bullous rash, interstitial nephritis, vision blurred, transient blindness, stomatitis, asthenia, cellulitis, folliculitis, paronychia, rash pustular, skin papilloma, hyperhidrosis, hypertension, leukopenia, lymphopenia, neutropenia, anemia, thrombocytopenia, increased AST, increased ALT, hyperbilirubinemia, increased GGT, hypoalbuminemia, hypokalemia, increased creatinine, hypomagnesemia, hyperkalemia, hypercalcemia, hypocalcemia, QT Prolongation"
13,TAFINLAR,warnings and precautions,"Retinal vein occlusion, Interstitial lung disease, New primary malignancies, Cutaneous malignancies, Non-cutaneous malignancies, Tumor Promotion in BRAF Wild-Type Melanoma, Hemorrhage, Major hemorrhagic events, Venous Thromboembolism, Deep vein thrombosis, Pulmonary embolism, Cardiomyopathy, Ocular Toxicities, Serious Febrile Reactions, Serious Skin Toxicity, Hyperglycemia, Glucose-6-Phosphate Dehydrogenase Deficiency, Embryofetal Toxicity, Cutaneous squamous cell carcinoma, Keratoacanthoma, Melanoma, Basal cell carcinoma, KRAS mutation-positive pancreatic adenocarcinoma, Recurrent NRAS mutation-positive colorectal carcinoma, Head and neck carcinoma, Glioblastoma, Retinal Pigment Epithelial Detachment (RPED), Uveitis, Iritis, death"
14,HORIZANT,adverse reactions,"Somnolence/sedation, dizziness, RLS, PHN, headache, nausea, dry mouth, flatulence, fatigue, irritability, feeling drunk, feeling abnormal, peripheral edema, weight increased, increased appetite, vertigo, depression, libido decreased, balance disorder, blurred vision, disorientation, lethargy, asthenia, insomnia, confusional state, breast enlargement, gynecomastia, elevated creatine kinase."
15,HORIZANT,warnings and precautions,"Driving impairment, Somnolence, Sedation, Dizziness, Suicidal thoughts, Suicidal behaviors, Fatigue, Asthenia, Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS), Multiorgan hypersensitivity, Fever, Rash, Lymphadenopathy, Hepatitis, Nephritis, Hematological abnormalities, Myocarditis, Myositis, Eosinophilia, Withdrawal seizure, Pancreatic acinar cell adenoma, Pancreatic acinar cell carcinoma, Tumorigenic potential, Death (due to fatal events mentioned with DRESS/multiorgan hypersensitivity and tumorigenic potential)"
16,IMBRUVICA,adverse reactions,"Hemorrhage, Infections, Cytopenias, Atrial Fibrillation, Second Primary Malignancies, Tumor Lysis Syndrome, thrombocytopenia, neutropenia, diarrhea, anemia, fatigue, musculoskeletal pain, bruising, nausea, upper respiratory tract infection, rash, peripheral edema, dyspnea, constipation, abdominal pain, vomiting, decreased appetite, pneumonia, skin infections, pyrexia, asthenia, petechiae, muscle spasms, arthralgia, cough, epistaxis, dehydration, dizziness, headache, stomatitis, dyspepsia, sinusitis, urinary tract infection, chills, laceration, anxiety, insomnia, hypertension, vision blurred, contusion, pruritus, arthropathy, skin cancer, hypersensitivity reactions, anaphylactic shock, urticaria, angioedema, renal failure, hyperuricemia, lymphocytosis, intracranial hemorrhage, lethargy, gait instability, subdural hematoma, oropharyngeal pain, peripheral neuropathy, second malignancies, death"
17,IMBRUVICA,warnings and precautions,"Hemorrhage, bleeding, Grade 3 or higher bleeding events, subdural hematoma, gastrointestinal bleeding, hematuria, post procedural hemorrhage, bruising, petechiae, death, Infections, fever, Grade 3 or greater infections, progressive multifocal leukoencephalopathy (PML), Cytopenias, neutropenia, thrombocytopenia, anemia, Atrial Fibrillation, atrial flutter, arrhythmic symptoms, palpitations, lightheadedness, dyspnea, Second Primary Malignancies, non-skin carcinomas, non-melanoma skin cancer, Tumor Lysis Syndrome, Embryo-Fetal Toxicity, fetal harm, malformations, reduced fetal weights"
18,ULORIC,adverse reactions,"liver function abnormalities, nausea, arthralgia, rash, dizziness, anemia, idiopathic thrombocytopenic purpura, leukocytosis, leukopenia, neutropenia, pancytopenia, splenomegaly, thrombocytopenia, angina pectoris, atrial fibrillation/flutter, cardiac murmur, ECG abnormal, palpitations, sinus bradycardia, tachycardia, deafness, tinnitus, vertigo, vision blurred, abdominal distention, abdominal pain, constipation, dry mouth, dyspepsia, flatulence, frequent stools, gastritis, gastroesophageal reflux disease, gastrointestinal discomfort, gingival pain, haematemesis, hyperchlorhydria, hematochezia, mouth ulceration, pancreatitis, peptic ulcer, vomiting, asthenia, chest pain/discomfort, edema, fatigue, feeling abnormal, gait disturbance, influenza-like symptoms, mass, pain, thirst, cholelithiasis, cholecystitis, hepatic steatosis, hepatitis, hepatomegaly, hypersensitivity, herpes zoster, contusion, anorexia, appetite decreased/increased, dehydration, diabetes mellitus, hypercholesterolemia, hyperglycemia, hyperlipidemia, hypertriglyceridemia, hypokalemia, weight decreased/increased, arthritis, joint stiffness, joint swelling, muscle spasms, muscle twitching, muscle tightness, muscle weakness, musculoskeletal pain, musculoskeletal stiffness, myalgia, altered taste, balance disorder, cerebrovascular accident, Guillain-Barre syndrome, headache, hemiparesis, hypoesthesia, hyposmia, lacunar infarction, lethargy, mental impairment, migraine, paresthesia, somnolence, transient ischemic attack, tremor, agitation, anxiety, depression, insomnia, irritability, libido decreased, nervousness, panic attack, personality change, hematuria, nephrolithiasis, pollakiuria, proteinuria, renal failure, renal insufficiency, urgency, incontinence, breast pain, erectile dysfunction, gynecomastia, bronchitis, cough, dyspnea, epistaxis, nasal dryness, paranasal sinus hypersecretion, pharyngeal edema, respiratory tract congestion, sneezing, throat irritation, upper respiratory tract infection, alopecia, angio-edema, dermatitis, dermographism, ecchymosis, eczema, hair color changes, hair growth abnormal, hyperhidrosis, peeling skin, petechiae, photosensitivity, pruritus, purpura, skin discoloration, altered pigmentation, skin lesion, skin odor abnormal, urticaria, flushing, hot flush, hypertension, hypotension, hepatic failure, jaundice, liver disorder, anaphylaxis, anaphylactic reaction, rhabdomyolysis, psychotic behavior, aggressive thoughts, tubulointerstitial nephritis, generalized rash, Stevens Johnson Syndrome, hypersensitivity skin reactions, death."
19,ULORIC,warnings and precautions,"gout flare, cardiovascular thromboembolic events, cardiovascular deaths, non-fatal myocardial infarctions, non-fatal strokes, hepatic failure, death, transaminase elevations, liver injury, fatigue, anorexia, right upper abdominal discomfort, dark urine, jaundice, severe drug-induced liver injury"
20,CIMZIA,adverse reactions,"upper respiratory tract infection, rash, urinary tract infection, serious infections, malignancies, heart failure, abdominal pain, diarrhea, intestinal obstruction, tuberculosis infections, pyrexia, urticaria, pneumonia, nasopharyngitis, laryngitis, viral infection, bladder infection, bacteriuria, cystitis, arthralgia, anemia, leukopenia, lymphadenopathy, pancytopenia, thrombophilia, angina pectoris, arrhythmias, atrial fibrillation, hypertensive heart disease, myocardial infarction, myocardial ischemia, pericardial effusion, pericarditis, stroke, transient ischemic attack, optic neuritis, retinal hemorrhage, uveitis, bleeding, injection site reactions, elevated liver enzymes, hepatitis, alopecia totalis, anxiety, bipolar disorder, suicide attempt, nephrotic syndrome, renal failure, menstrual disorder, dermatitis, erythema nodosum, thrombophlebitis, vasculitis, headache, hypertension, back pain, pharyngitis, acute bronchitis, fatigue, systemic vasculitis, Stevens-Johnson syndrome, toxic epidermal necrolysis, erythema multiforme, new or worsening psoriasis, sarcoidosis"
21,CIMZIA,boxed warnings,"serious infections, hospitalization, death, concomitant immunosuppressants, methotrexate, corticosteroids, sepsis, active tuberculosis, reactivation of latent tuberculosis, disseminated disease, extrapulmonary disease, latent tuberculosis, invasive fungal infections, histoplasmosis, coccidioidomycosis, candidiasis, aspergillosis, blastomycosis, pneumocystosis, bacterial infections, viral infections, opportunistic pathogens, Legionella, Listeria, chronic infection, recurrent infection, malignancy, lymphoma, other malignancies"
22,CIMZIA,warnings and precautions,"serious infections, active infection, invasive fungal infections, systemic illness, mycoses, lymphoma, malignancies, heart failure, worsening heart failure, new onset heart failure, anaphylaxis, serious allergic reactions, hepatitis B virus reactivation, demyelinating disease, exacerbation of demyelinating disease, new onset demyelinating disease, cytopenias, pancytopenia, lupus-like syndrome, opportunistic infections, bacterial infections, mycobacterial infections, viral infections, parasitic infections, aspergillosis, blastomycosis, candidiasis, coccidioidomycosis, histoplasmosis, legionellosis, listeriosis, pneumocystosis, tuberculosis, chronic infection, recurrent infection, tuberculosis exposure, opportunistic infection history, endemic tuberculosis, endemic mycoses, predisposing conditions to infection, reactivation of tuberculosis, new tuberculosis infections, latent tuberculosis, hepatosplenic T-cell lymphoma (HSTCL), acute leukemia, chronic leukemia, skin cancer, congestive heart failure (CHF), hypersensitivity reactions, angioedema, dyspnea, hypotension, rash, serum sickness, urticaria, central nervous system demyelinating disease, multiple sclerosis, peripheral demyelinating disease, Guillain-Barre syndrome, seizure disorder, optic neuritis, peripheral neuropathy, aplastic anemia, leukopenia, thrombocytopenia, blood dyscrasias, infection signs (e.g., fever, bruising, bleeding, pallor), autoantibodies, lupus-like syndrome, immunosuppression, death"
23,KALYDECO,adverse reactions,"Transaminase Elevations, headache, oropharyngeal pain, upper respiratory tract infection, nasal congestion, abdominal pain, nasopharyngitis, diarrhea, rash, nausea, dizziness, hypoglycemia, rhinitis, arthralgia, bacteria in sputum, aspartate aminotransferase increased, blood glucose increased, hepatic enzyme increased, musculoskeletal chest pain, myalgia, sinus headache, pharyngeal erythema, pleuritic pain, sinus congestion, wheezing, acne"
24,KALYDECO,warnings and precautions,"Elevated transaminases, ALT elevations, AST elevations, increased transaminase levels, transaminase elevations, non-congenital lens opacities, cataracts"
25,FULYZAQ,adverse reactions,"upper respiratory tract infection, bronchitis, cough, flatulence, increased bilirubin, nausea, back pain, arthralgia, urinary tract infection, nasopharyngitis, musculoskeletal pain, hemorrhoids, giardiasis, anxiety, increased alanine aminotransferase, abdominal distension, abdominal pain, acne, increased aspartate aminotransferase, increased conjugated bilirubin, increased unconjugated blood bilirubin, constipation, depression, dermatitis, dizziness, dry mouth, dyspepsia, gastroenteritis, herpes zoster, nephrolithiasis, pain in extremity, pollakiuria, procedural pain, seasonal allergy, sinusitis, decreased white blood cell count"
26,FULYZAQ,warnings and precautions,worsening of disease
27,QUTENZA,adverse reactions,"Application-Associated Pain, Increase in Blood Pressure, application site erythema, application site pain, application site pruritus, application site papules, application site edema, application site swelling, application site dryness, nasopharyngitis, bronchitis, sinusitis, nausea, vomiting, pruritus, hypertension, application site urticaria, application site paresthesia, application site dermatitis, application site hyperesthesia, application site excoriation, application site warmth, application site anesthesia, application site bruising, application site inflammation, application site exfoliation, peripheral edema, headache, burning sensation, peripheral sensory neuropathy, dizziness, dysgeusia, hyperesthesia, hypoesthesia, cough, throat irritation, abnormal skin odor"
28,QUTENZA,warnings and precautions,"coughing, sneezing, irritation of eyes, irritation of airway, transient increases in blood pressure, procedural pain, acute pain, increases in blood pressure, adverse cardiovascular effects"
29,GRANIX,adverse reactions,"Splenic Rupture, Acute Respiratory Distress Syndrome, Serious Allergic Reactions, Capillary Leak Syndrome, Tumor Growth Stimulatory Effects on Malignant Cells, Bone Pain, Leukocytosis, Myalgia, Headache, Vomiting, Sweet's Syndrome, Cutaneous Vasculitis, Thrombocytopenia"
30,GRANIX,warnings and precautions,"Splenic Rupture, Acute Respiratory Distress Syndrome (ARDS), Allergic reactions, angioneurotic edema, dermatitis allergic, drug hypersensitivity, hypersensitivity, rash, pruritic rash, urticaria, Sickle cell crisis, Capillary Leak Syndrome (CLS), hypotension, hypoalbuminemia, edema, hemoconcentration, death"
31,COARTEM,adverse reactions,"headache, anorexia, dizziness, asthenia, arthralgia, myalgia, pyrexia, cough, vomiting, chills, fatigue, malaise, nausea, abdominal pain, diarrhea, sleep disorder, insomnia, palpitations, hepatomegaly, splenomegaly, anemia, pruritus, rash, vertigo, malaria, nasopharyngitis, Plasmodium falciparum infection, rhinitis, aspartate aminotransferase increased, eosinophilia, tinnitus, conjunctivitis, constipation, dyspepsia, dysphagia, peptic ulcer, gait disturbance, abscess, acrodermatitis, bronchitis, ear infection, gastroenteritis, helminthic infection, hookworm infection, impetigo, influenza, lower respiratory tract infection, oral herpes, pneumonia, respiratory tract infection, subcutaneous abscess, upper respiratory tract infection, urinary tract infection, alanine aminotransferase increased, hematocrit decreased, lymphocyte morphology abnormal, platelet count decreased, platelet count increased, white blood cell count decreased, white blood cell count increased, hypokalemia, back pain, ataxia, clonus, fine motor delay, hyperreflexia, hypoesthesia, nystagmus, tremor, agitation, mood swings, hematuria, proteinuria, asthma, pharyngo-laryngeal pain, urticaria, anaphylaxis, angioedema, serious skin reactions (bullous eruption)"
32,COARTEM,warnings and precautions,"QT prolongation, hypokalemia, hypomagnesemia, cardiac arrhythmias, bradycardia, severe cardiac disease, sudden death, electrolyte balance disturbances, decreased efficacy, decreased exposure to lumefantrine, decreased bile production, increased concentrations of artemether and/or lumefantrine, loss of antimalarial efficacy, reduced effectiveness of hormonal contraceptives, increased risk of adverse effects, recrudescence, hepatic impairment, renal impairment, relapsing malaria, death"
33,APTIOM,adverse reactions,"Suicidal Behavior and Ideation, Serious Dermatologic Reactions, Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS), Multiorgan Hypersensitivity, Anaphylactic Reactions, Angioedema, Hyponatremia, Neurological Adverse Reactions, Drug Induced Liver Injury, Abnormal Thyroid Function Tests, dizziness, somnolence, nausea, headache, diplopia, vomiting, fatigue, vertigo, ataxia, blurred vision, tremor, asthenia, rash, dysarthria, ear and labyrinth disorders, eye disorders, visual impairment, gastrointestinal disorders, diarrhea, constipation, abdominal pain, gastritis, general disorders and administration site conditions, gait disturbance, peripheral edema, infections and infestations, urinary tract infections, injury, poisoning and procedural complications, fall, metabolism and nutrition disorders, nervous system disorders, balance disorder, memory impairment, nystagmus, psychiatric disorders, depression, insomnia, respiratory, thoracic and mediastinal disorders, cough, skin and subcutaneous tissue disorders, vascular disorders, hypertension, decreases in hemoglobin and hematocrit, increases in total cholesterol, triglycerides, LDL, increases in creatine phosphokinase."
34,APTIOM,warnings and precautions,"Suicidal thoughts or behavior, suicidal ideation, depression, mood changes, behavior changes, self-harm, Stevens-Johnson Syndrome (SJS), toxic epidermal necrolysis (TEN), serious dermatologic reactions, Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS), Multiorgan Hypersensitivity, anaphylactic reactions, angioedema, laryngeal edema, hyponatremia, seizures, nausea, vomiting, dehydration, gait instability, injury, hypochloremia, dizziness, disturbance in gait and coordination, ataxia, vertigo, balance disorder, gait disturbance, nystagmus, abnormal coordination, somnolence, fatigue, asthenia, malaise, hypersomnia, sedation, lethargy, cognitive dysfunction, memory impairment, disturbance in attention, amnesia, confusional state, aphasia, speech disorder, slowness of thought, disorientation, psychomotor retardation, visual changes, diplopia, blurred vision, impaired vision, increased seizure frequency, status epilepticus, liver injury, jaundice, transaminase elevations, bilirubin elevations, abnormal thyroid function tests, decreased serum T3, decreased serum T4, death (due to fatal events mentioned such as fatal dermatologic reactions, life-threatening complications from hyponatremia, and fatal DRESS)."
35,PROLIA,adverse reactions,"Hypocalcemia, Serious Infections, Dermatologic Adverse Reactions, Osteonecrosis of the Jaw, Atypical Subtrochanteric and Diaphyseal Femoral Fractures, back pain, pain in extremity, musculoskeletal pain, hypercholesterolemia, cystitis, arthralgia, nasopharyngitis, constipation, anemia, angina pectoris, atrial fibrillation, vertigo, abdominal pain upper, flatulence, gastroesophageal reflux disease, edema peripheral, asthenia, upper respiratory tract infection, pneumonia, pharyngitis, herpes zoster, bone pain, myalgia, spinal osteoarthritis, sciatica, insomnia, rash, pruritus, pancreatitis, death, new malignancies, cataracts, drug-related hypersensitivity reactions, anaphylaxis, rash, urticaria, facial swelling, erythema, severe symptomatic hypocalcemia, severe musculoskeletal pain, marked elevation in serum PTH."
36,PROLIA,warnings and precautions,"hypersensitivity, anaphylactic reactions, hypocalcemia, osteonecrosis of the jaw, atypical femoral fractures, serious infections, skin infections, hospitalization, dermatologic reactions, dermatitis, rashes, eczema, severe bone pain, joint pain, muscle pain, suppression of bone turnover, hypotension, dyspnea, throat tightness, facial edema, upper airway edema, pruritus, urticaria, mineral metabolism disturbances, marked elevations of serum parathyroid hormone (PTH), infections of the abdomen, urinary tract infections, ear infections, endocarditis, opportunistic infections, epidermal adverse events, dermal adverse events, incapacitating bone pain, incapacitating joint pain, incapacitating muscle pain, delayed fracture healing"
37,BLINCYTO,adverse reactions,"Cytokine Release Syndrome, Neurological Toxicities, Infections, Tumor Lysis Syndrome, Neutropenia, Febrile Neutropenia, Effects on Ability to Drive and Use Machines, Elevated Liver Enzymes, Leukoencephalopathy, Preparation and Administration Errors, Pyrexia, Headache, Peripheral Edema, Nausea, Hypokalemia, Tremor, Rash, Constipation, Pneumonia, Sepsis, Device-related Infection, Encephalopathy, Overdose, Confusion, Staphylococcal Bacteremia, Anemia, Thrombocytopenia, Leukopenia, Diarrhea, Abdominal Pain, Vomiting, Fatigue, Chills, Chest Pain, Cytokine Release Syndrome, Other Pathogen Infections, Bacterial Infections, Fungal Infections, Viral Infections, Increased Alanine Aminotransferase, Increased Aspartate Aminotransferase, Increased Weight, Hypomagnesemia, Hyperglycemia, Decreased Appetite, Hypophosphatemia, Back Pain, Pain in Extremity, Bone Pain, Arthralgia, Dizziness, Insomnia, Cough, Dyspnea, Hypotension, Hypertension, Leukocytosis, Lymphopenia, Tachycardia, Edema, Cytokine Storm, Decreased Immunoglobulins, Increased Blood Bilirubin, Increased Gamma-Glutamyl-Transferase, Increased Liver Enzymes, Tumor Lysis Syndrome, Hypoalbuminemia, Paresthesia, Aphasia, Convulsion, Memory Impairment, Cognitive Disorder, Speech Disorder, Confusion, Disorientation, Capillary Leak Syndrome, Hypersensitivity, Bronchospasm, death"
38,BLINCYTO,boxed warnings,"Cytokine Release Syndrome, CRS, life-threatening, fatal, Neurological toxicities, severe, death"
39,BLINCYTO,warnings and precautions,"Infections, signs or symptoms of infection, Effects on Ability to Drive and Use Machines, Preparation and Administration Errors, Cytokine Release Syndrome (CRS), life-threatening CRS, fatal CRS, Infusion reactions, pyrexia, headache, nausea, asthenia, hypotension, increased alanine aminotransferase, increased aspartate aminotransferase, increased total bilirubin, BLINCYTO discontinuation, disseminated intravascular coagulation (DIC), capillary leak syndrome (CLS), hemophagocytic lymphohistiocytosis/macrophage activation syndrome (HLH/MAS), Neurological Toxicities, encephalopathy, convulsions, speech disorders, disturbances in consciousness, confusion and disorientation, coordination and balance disorders, Tumor Lysis Syndrome (TLS), Neutropenia, febrile neutropenia, Elevated Liver Enzymes, transient elevations in liver enzymes, Grade 3 or greater elevations in liver enzymes, Leukoencephalopathy, death"
40,STENDRA,adverse reactions,"headache, flushing, nasal congestion, nasopharyngitis, back pain, upper respiratory infection, bronchitis, influenza, sinusitis, sinus congestion, hypertension, dyspepsia, nausea, constipation, rash, dizziness, arthralgia, diarrhea, edema peripheral, fatigue, angina, unstable angina, deep vein thrombosis, palpitations, gastritis, gastroesophageal reflux disease, hypoglycemia, blood glucose increased, alanine aminotransferase increased, oropharyngeal pain, stomach discomfort, vomiting, muscle spasms, musculoskeletal pain, myalgia, pain in extremity, depression, insomnia, somnolence, vertigo, cough, dyspnea exertional, epistaxis, wheezing, pruritus, balanitis, erection increased, hematuria, nephrolithiasis, pollakiuria, urinary tract infection, electrocardiogram abnormal, gastroenteritis viral, non-arteritic anterior ischemic optic neuropathy (NAION), decreased vision, vision loss"
41,STENDRA,warnings and precautions,"hypotension, prolonged erection, priapism, penile tissue damage, permanent loss of potency, sudden loss of vision, Non Arteritic Ischemic Optic Neuropathy (NAION), sudden decrease or loss of hearing, tinnitus, dizziness, headache, symptomatic hypotension, lightheadedness, fainting, orthostatic signs and symptoms, increase in heart rate, decrease in standing blood pressure, effects on bleeding, bleeding disorders, active peptic ulceration, anti-aggregatory effect"
42,XIAFLEX,adverse reactions,"Tendon ruptures, serious injury to the injected extremity, Corporal rupture (penile fracture), severe penile hematoma, penile ecchymoses, sudden penile detumescence, penile ""popping"" sound or sensation, edema peripheral (swelling of the injected hand), contusion, injection site hemorrhage, injection site reaction, pain in the injected extremity, penile swelling, penile pain, pruritus, lymphadenopathy, axillary mass, skin laceration, lymph node pain, erythema, axillary pain, vasovagal syncope, blood blister, injection site hematoma, ecchymosis, injection site swelling, injection site pruritus, penile blister, pruritus genital, painful erection, erectile dysfunction, skin discoloration, procedural pain, injection site vesicles, localized edema, dyspareunia, nodule, suprapubic pain, severe injection site hematoma, penile ""popping"" sounds or sensations, death"
43,XIAFLEX,boxed warnings,"corporal rupture, penile fracture, serious penile injury, penile ecchymoses, hematoma, sudden penile detumescence, penile ""popping"" sound, penile ""popping"" sensation, severe penile hematoma, death"
44,XIAFLEX,warnings and precautions,"tendon rupture, serious injury, injected finger/hand injury, permanent injury, ligament damage, skin laceration, corporal rupture (penile fracture), serious injury to the penis, hypersensitivity reactions, anaphylaxis, abnormal coagulation, flexor tendon ruptures, damage to collagen-containing structures, pulley rupture, ligament injury, complex regional pain syndrome (CRPS), sensory abnormality of the hand, skin tear, penile ecchymoses, penile hematoma, sudden penile detumescence, penile ""popping"" sound or sensation, severe penile hematoma, allergic reactions, pruritus, IgE-anti-drug antibodies, ecchymosis/contusion, injection site hemorrhage, penile ecchymosis, bleeding"
45,XEOMIN,adverse reactions,"hypersensitivity, dysphagia, breathing difficulties, spread of effects from toxin, neck pain, muscle weakness, injection site pain, musculoskeletal pain, eyelid ptosis, dry eye, dry mouth, diarrhea, headache, visual impairment, dyspnea, nasopharyngitis, respiratory tract infection, facial paresis, injection site hematoma, eyelid edema, facial pain, injection site swelling, sensation of pressure, blepharospasm, eye disorder, immunogenicity, eye swelling, nausea, flu-like symptoms, injection site reaction, allergic dermatitis, localized allergic reactions, swelling, edema, erythema, pruritus, rash, herpes zoster, muscle spasm, dysarthria, myalgia, hypersensitivity"
46,XEOMIN,boxed warnings,"asthenia, generalized muscle weakness, diplopia, blurred vision, ptosis, dysphagia, dysphonia, dysarthria, urinary incontinence, breathing difficulties, death"
47,XEOMIN,warnings and precautions,"respiratory difficulties, speech difficulties, swallowing difficulties, compromised respiratory function, dysphagia, neuromuscular disorders, cervical dystonia, smaller neck muscle mass, sternocleidomastoid muscle injections, corneal exposure, corneal ulceration, reduced blinking, diplopia, lower lid injections, ptosis, asthenia, generalized muscle weakness, blurred vision, dysphonia, dysarthria, urinary incontinence, breathing difficulties, hypersensitivity reactions, anaphylaxis, serum sickness, urticaria, soft tissue edema, dyspnea, severe dysphagia, aspiration, respiratory failure, peripheral motor neuropathic diseases, amyotrophic lateral sclerosis, neuromuscular junctional disorders, myasthenia gravis, Lambert-Eaton syndrome, ectropion, VII nerve disorders, narrow angle glaucoma, ecchymosis, levator palpebrae superioris, corrugator injections, supraorbital ridge, death"
48,GILOTRIF,adverse reactions,"Diarrhea, Bullous Skin Disorders, Exfoliative Skin Disorders, Interstitial Lung Disease, Hepatic Toxicity, Keratitis, rash, dermatitis acneiform, stomatitis, paronychia, dry skin, decreased appetite, nausea, vomiting, pruritus, pulmonary toxicity, ILD-like adverse reactions, sepsis, pneumonia, ventricular dysfunction, diastolic dysfunction, left ventricular dysfunction, ventricular dilation, cheilitis, cystitis, epistaxis, rhinorrhea, weight decreased, pyrexia, conjunctivitis, alanine aminotransferase increased, hypokalemia, aspartate aminotransferase increased, pancreatitis, death"
49,GILOTRIF,warnings and precautions,"Diarrhea, dehydration, renal failure, bullous skin disorders, exfoliative skin disorders, blistering lesions, exfoliating lesions, interstitial lung disease (ILD), lung infiltration, pneumonitis, acute respiratory distress syndrome, alveolitis allergic, hepatic toxicity, fatal hepatic impairment, liver test abnormalities, keratitis, eye inflammation, lacrimation, light sensitivity, blurred vision, eye pain, red eye, ulcerative keratitis, severe dry eye, embryofetal toxicity, fetal harm, abortions, death"
50,TREANDA,adverse reactions,"myelosuppression, infections, anaphylaxis, infusion reactions, tumor lysis syndrome, skin reactions, other malignancies, extravasation injury, pyrexia, nausea, vomiting, fatigue, diarrhea, constipation, anorexia, cough, headache, weight decreased, dyspnea, rash, stomatitis, lymphopenia, anemia, leukopenia, thrombocytopenia, neutropenia, asthenia, malaise, weakness, dry mouth, somnolence, mucosal inflammation, hypertension, hypertensive crisis, hypersensitivity, nasopharyngitis, infection, herpes simplex, hyperuricemia, pruritus, hemoglobin decreased, platelets decreased, leukocytes decreased, lymphocytes decreased, neutrophils decreased, bilirubin increased, AST increased, ALT increased, creatinine levels changes, tachycardia, constipation, stomatitis, abdominal pain, dyspepsia, gastroesophageal reflux disease, abdominal pain upper, abdominal distension, edema peripheral, chest pain, infusion site pain, pain, catheter site pain, herpes zoster, upper respiratory tract infection, urinary tract infection, sinusitis, pneumonia, febrile neutropenia, oral candidiasis, weight decreased, anorexia, dehydration, decreased appetite, hypokalemia, back pain, arthralgia, pain in extremity, bone pain, headache, dizziness, dysgeusia, insomnia, anxiety, depression, cough, dyspnea, pharyngolaryngeal pain, wheezing, nasal congestion, dry skin, night sweats, hyperhidrosis, hypotension, acute renal failure, cardiac failure, pulmonary fibrosis, myelodysplastic syndrome, hemolysis, taste disorder, atypical pneumonia, sepsis, erythema, dermatitis, skin necrosis, anaphylaxis, phlebitis, pruritus, irritation, pain, swelling, pneumocystis jiroveci pneumonia, pneumonitis, Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN)"
51,TREANDA,warnings and precautions,"myelosuppression, death, infections, fever, signs of infection, anaphylaxis, infusion reactions, severe anaphylactic reactions, tumor lysis syndrome, acute renal failure, skin reactions, severe skin reactions, Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), pre-malignant diseases, malignant diseases, myelodysplastic syndrome, myeloproliferative disorders, acute myeloid leukemia, bronchial carcinoma, extravasation injury, erythema, swelling, pain, infection, necrosis, embryo-fetal toxicity, fetal harm, resorptions, skeletal malformations, visceral malformations, decreased fetal body weights, neutropenic sepsis, diffuse alveolar hemorrhage, thrombocytopenia, pneumonia, opportunistic infection, CMV, sepsis, septic shock, fever, chills, pruritus, rash, allergic-type reactions, bullous exanthema, toxic skin reactions, redness, swelling, pain, infection, necrosis"
52,CHOLINE,adverse reactions,mild injection site reaction
53,CHOLINE,warnings and precautions,"Imaging errors, allergic reactions, anaphylaxis, radiation risk, cancer risk, poor imaging performance, false positive results, false negative results, tissue inflammation, prostatic hyperplasia, interference with imaging"
54,ERWINAZE,adverse reactions,"hypersensitivity reactions, pancreatitis, glucose intolerance, thrombosis, hemorrhage, systemic hypersensitivity, hyperglycemia, transaminases abnormal, fever, local reactions, vomiting, nausea, hyperbilirubinemia, abdominal pain/discomfort, diarrhea, allergy, coagulopathy, hyperlipidemia, ketoacidosis, CNS events, hepatobiliary disorders, pancreatic disorders, anti-drug antibodies (ADA)"
55,ERWINAZE,warnings and precautions,"serious hypersensitivity reactions, anaphylaxis, severe pancreatitis, hemorrhagic pancreatitis, glucose intolerance, hyperglycemia, thrombosis, hemorrhage, sagittal sinus thrombosis, pulmonary embolism, decreased fibrinogen, decreased protein C activity, decreased protein S activity, decreased anti-thrombin III"
56,TRULICITY,adverse reactions,"Thyroid C-cell Tumors, Pancreatitis, Hypoglycemia, Hypersensitivity reactions, Renal impairment, Severe Gastrointestinal Disease, Nausea, Diarrhea, Vomiting, Abdominal pain, Decreased appetite, Dyspepsia, Fatigue, Constipation, Flatulence, Abdominal distension, Gastroesophageal reflux disease, Eructation, Documented symptomatic hypoglycemia, Severe hypoglycemia, Heart Rate Increase, Tachycardia, Sinus tachycardia, Immunogenicity, Anti-drug antibodies, Dulaglutide-neutralizing antibodies, Antibodies against native GLP-1, Systemic hypersensitivity, Severe urticaria, Systemic rash, Facial edema, Lip swelling, Injection-site reactions, Injection-site rash, Erythema, PR Interval Prolongation, First Degree Atrioventricular Block, Amylase increase, Lipase increase"
57,TRULICITY,boxed warnings,"thyroid C-cell tumors, adenomas, carcinomas, medullary thyroid carcinoma (MTC), mass in the neck, dysphagia, dyspnea, persistent hoarseness"
58,TRULICITY,warnings and precautions,"Thyroid C-cell Tumors, Pancreatitis, Hypoglycemia, Hypersensitivity Reactions, Renal Impairment, Macrovascular outcomes, Medullary Thyroid Carcinoma (MTC), Severe Gastrointestinal Disease, Severe Gastroparesis, Acute Renal Failure, Worsening of Chronic Renal Failure, Nausea, Vomiting, Diarrhea, Dehydration"
59,ADREVIEW,adverse reactions,"hypersensitivity reactions, dizziness, rash, pruritis, flushing, headache, injection site hemorrhage, hematoma, bruising"
60,ADREVIEW,warnings and precautions,"Hypersensitivity reactions, anaphylactic reactions, withdrawal signs and symptoms, serious reactions, severe renal impairment, increased radiation exposure, decreased quality of images, iodine 123 accumulation, thyroid neoplasia, benzyl alcohol toxicity, hypotension, metabolic acidosis, kernicterus, Gasping Syndrome, death, decreased cardiac uptake, transient episode of hypertension"
61,DOTAREM,adverse reactions,"NSF, hypersensitivity reactions, acute kidney injury, nausea, headache, injection site pain, injection site coldness, burning sensation, feeling cold, rash, somnolence, fatigue, dizziness, vomiting, pruritus, paresthesia, dysgeusia, pain in extremity, anxiety, hypertension, palpitations, oropharyngeal discomfort, serum creatinine increased, injection site reactions, site inflammation, extravasation, warmth, bradycardia, tachycardia, arrhythmia, anaphylactoid reactions, cardiac arrest, respiratory arrest, cyanosis, pharyngeal edema, laryngospasm, bronchospasm, angioedema, conjunctivitis, ocular hyperemia, eyelid edema, lacrimation increased, hyperhidrosis, urticaria, coma, convulsion, syncope, presyncope, parosmia, tremor, muscle contracture, muscle weakness, diarrhea, salivary hypersecretion, malaise, fever, superficial phlebitis"
62,DOTAREM,boxed warnings,"Nephrogenic Systemic Fibrosis (NSF), fatal, debilitating fibrosis, skin fibrosis, muscle fibrosis, internal organ fibrosis, Chronic severe kidney disease, Acute kidney injury, reduced renal function, hypertension, diabetes, death"
63,DOTAREM,warnings and precautions,"Nephrogenic Systemic Fibrosis, impaired elimination of GBCAs, Hypersensitivity, Anaphylactoid reactions, anaphylactic reactions, cardiovascular manifestations, respiratory manifestations, cutaneous manifestations, death, fatal fibrosis, skin fibrosis, muscle fibrosis, internal organ fibrosis, acute kidney injury, drug-induced kidney toxicity, NSF, circulatory collapse, allergic disorders, bronchial asthma, Acute Kidney Injury requiring dialysis, renal impairment, Extravasation, tissue irritation, Injection Site Reactions"
64,PRADAXA,adverse reactions,"bleeding, gastritis-like symptoms, gastrointestinal hemorrhage, dyspepsia, nausea, upper abdominal pain, diarrhea, hemorrhagic stroke, intracranial hemorrhage, intracerebral hemorrhage, subarachnoid hemorrhage, subdural hemorrhage, gastrointestinal bleeds, major bleeding, fatal bleeding, hypersensitivity reactions, urticaria, rash, pruritus, allergic edema, anaphylactic reaction, anaphylactic shock, deep venous thrombosis, pulmonary embolism, symptomatic bleeding, intraocular bleeding, intraspinal bleeding, intramuscular bleeding with compartment syndrome, retroperitoneal bleeding, intra-articular bleeding, pericardial bleeding, gastrointestinal adverse reactions, GERD, esophagitis, erosive gastritis, gastric hemorrhage, hemorrhagic gastritis, hemorrhagic erosive gastritis, gastrointestinal ulcer, myocardial infarction, angioedema, thrombocytopenia, esophageal ulcer, death"
65,PRADAXA,boxed warnings,"thrombotic events, spinal/epidural hematoma, pathological bleeding, long-term paralysis, permanent paralysis, neurological impairment"
66,PRADAXA,warnings and precautions,"serious bleeding, fatal bleeding, thrombotic events, blood loss, hypotension, pathological bleeding, spinal hematoma, permanent paralysis, valve thrombosis, stroke, transient ischemic attack, myocardial infarction, major bleeding, pericardial effusions, neurological impairment, back pain, sensory deficits, motor deficits, numbness, tingling, weakness in lower limbs, bowel dysfunction, bladder dysfunction, death"
67,ELIQUIS,adverse reactions,"thrombotic events, bleeding, spinal/epidural anesthesia or puncture, hemorrhagic stroke, intracranial bleed, gastrointestinal (GI) bleed, fatal bleeding, intracranial bleeding, non-intracranial bleeding, hypersensitivity reactions, skin rash, anaphylactic reactions, allergic edema, syncope, deep vein thrombosis, prophylaxis, nausea, anemia, contusion, hemorrhage, postprocedural hemorrhage, transaminases increased, aspartate aminotransferase increased, gamma-glutamyltransferase increased, thrombocytopenia, hypotension, epistaxis, gastrointestinal hemorrhage, hematemesis, melena, hematochezia, liver function test abnormal, blood alkaline phosphatase increased, blood bilirubin increased, hematuria, wound secretion, incision-site hemorrhage, operative hemorrhage, gingival bleeding, hemoptysis, hypersensitivity, muscle hemorrhage, ocular hemorrhage, conjunctival hemorrhage, rectal hemorrhage, hemorrhagic anemia, hemorrhoidal hemorrhage, wound hemorrhage, traumatic hematoma, periorbital hematoma, vaginal hemorrhage, metrorrhagia, menometrorrhagia, genital hemorrhage, ecchymosis, skin hemorrhage, petechiae, conjunctival hemorrhage, retinal hemorrhage, eye hemorrhage, blood urine present, occult blood positive, red blood cells urine positive, injection-site hematoma, vessel puncture-site hematoma, death"
68,ELIQUIS,boxed warnings,"thrombotic events, spinal hematoma, epidural hematoma, paralysis, neurological impairment, death"
69,ELIQUIS,warnings and precautions,"serious bleeding, fatal bleeding, blood loss, thrombotic events, stroke, bleeding, pathological bleeding, hemorrhage, epidural hematoma, spinal hematoma, paralysis, neurological impairment, numbness, weakness of the legs, bowel dysfunction, bladder dysfunction, death"
70,ZERBAXA,adverse reactions,"Hypersensitivity reactions, Clostridium difficile-associated diarrhea, nausea, diarrhea, headache, pyrexia, constipation, insomnia, vomiting, hypokalemia, ALT increased, AST increased, anemia, thrombocytosis, abdominal pain, anxiety, dizziness, hypotension, atrial fibrillation, rash, renal impairment, renal failure, cardiac disorders, tachycardia, angina pectoris, gastrointestinal disorders, ileus, gastritis, abdominal distension, dyspepsia, flatulence, ileus paralytic, general disorders and administration site conditions, infusion site reactions, infections and infestations, candidiasis, oropharyngeal, fungal urinary tract infection, investigations, increased serum gamma-glutamyl transpeptidase (GGT), increased serum alkaline phosphatase, positive Coombs test, metabolism and nutrition disorders, hyperglycemia, hypomagnesemia, hypophosphatemia, nervous system disorders, ischemic stroke, respiratory, thoracic and mediastinal disorders, dyspnea, skin and subcutaneous tissue disorders, urticaria, vascular disorders, venous thrombosis, death"
71,ZERBAXA,warnings and precautions,"decreased efficacy, serious hypersensitivity reactions, anaphylactic reactions, Clostridium difficile-associated diarrhea (CDAD), mild diarrhea, fatal colitis, death"
72,FERRIPROX,adverse reactions,"chromaturia, nausea, vomiting, abdominal pain, alanine aminotransferase increased, arthralgia, neutropenia, agranulocytosis, decreased plasma zinc concentrations, diarrhea, dyspepsia, neutrophil count decreased, weight increased, aspartate aminotransferase increased, increased appetite, decreased appetite, back pain, pain in extremity, arthropathy, headache, thrombocytosis, pancytopenia, atrial fibrillation, cardiac failure, hypospadias, diplopia, papilledema, retinal toxicity, enterocolitis, rectal hemorrhage, gastric ulcer, pancreatitis, parotid gland enlargement, chills, pyrexia, edema peripheral, multi-organ failure, death, jaundice, hepatomegaly, anaphylactic shock, hypersensitivity, cryptococcal cutaneous infection, enteroviral encephalitis, pharyngitis, pneumonia, sepsis, furuncle, infectious hepatitis, rash pustular, subcutaneous abscess, blood bilirubin increased, blood creatinine phosphokinase increased, metabolic acidosis, dehydration, myositis, chondropathy, trismus, cerebellar syndrome, cerebral hemorrhage, convulsion, gait disturbance, intracranial pressure increased, psychomotor skills impaired, pyramidal tract syndrome, somnolence, bruxism, depression, obsessive-compulsive disorder, glycosuria, hemoglobinuria, acute respiratory distress syndrome, epistaxis, hemoptysis, pulmonary embolism, hyperhidrosis, periorbital edema, photosensitivity reaction, pruritis, urticaria, rash, Henoch-Schonlein purpura, hypotension, hypertension"
73,FERRIPROX,boxed warnings,"agranulocytosis, neutropenia, serious infections, death, infection"
74,FERRIPROX,warnings and precautions,"infection, fetal harm, avoid pregnancy, agranulocytosis, neutropenia, death, embryofetal death, malformations, increased ALT values, increased AST values, decreased plasma zinc concentrations"
75,DALVANCE,adverse reactions,"nausea, headache, diarrhea, vomiting, rash, pruritus, anemia, hemorrhagic anemia, leucopenia, neutropenia, thrombocytopenia, petechiae, eosinophilia, thrombocytosis, gastrointestinal hemorrhage, melena, hematochezia, abdominal pain, infusion-related reactions, hepatotoxicity, anaphylactoid reaction, Clostridium difficile colitis, oral candidiasis, vulvovaginal mycotic infection, hepatic transaminases increased, blood alkaline phosphatase increased, international normalized ratio increased, hypoglycemia, dizziness, bronchospasm, urticaria, flushing, phlebitis, wound hemorrhage, spontaneous hematoma"
76,DALVANCE,warnings and precautions,"serious hypersensitivity, anaphylactic reactions, skin reactions, hypersensitivity to glycopeptides, rapid intravenous infusion reactions, Red-Man Syndrome, flushing of the upper body, urticaria, pruritus, rash, ALT elevations, liver test abnormalities, AST elevation, bilirubin elevation, Clostridium difficile-associated diarrhea (CDAD), mild diarrhea, fatal colitis, morbidity, mortality, fluid and electrolyte management disturbances, protein supplementation requirements, surgical evaluation necessity, drug-resistant bacteria development, death"
77,ARCAPTA,adverse reactions,"asthma-related death, cough, oropharyngeal pain, nasopharyngitis, headache, nausea, COPD, dyspnea, COPD exacerbation, pneumonia, angina pectoris, atrial fibrillation, muscle spasm, musculoskeletal pain, edema peripheral, diabetes mellitus, hyperglycemia, sinusitis, upper respiratory tract infection, hypersensitivity reactions, paradoxical bronchospasm, tachycardia, heart rate increase, palpitations, pruritus, rash, dizziness, death"
78,ARCAPTA,boxed warnings,"asthma-related death, death"
79,ARCAPTA,warnings and precautions,"acutely deteriorating COPD, cardiovascular effects, fatal, death, Immediate hypersensitivity reactions, paradoxical bronchospasm, life-threatening, cardiovascular disorders, convulsive disorders, thyrotoxicosis, sensitivity to sympathomimetic drugs, asthma-related death, serious asthma-related events, deterioration of disease, acute episodes of bronchospasm, excessive use of inhaled sympathomimetic drugs, difficulties in breathing, swallowing, swelling of tongue, lips and face, urticaria, skin rash, increases in pulse rate, systolic blood pressure, diastolic blood pressure, ECG changes, flattening of the T wave, prolongation of the QTc interval, ST segment depression, coronary insufficiency, cardiac arrhythmias, hypertension, convulsive disorders, aggravate pre-existing diabetes mellitus, ketoacidosis, hypokalemia, hyperglycemia, increases in plasma glucose"
80,CERDELGA,adverse reactions,"fatigue, headache, nausea, diarrhea, back pain, pain in extremities, upper abdominal pain, arthralgia, migraine, flatulence, oropharyngeal pain, dizziness, asthenia, cough, dyspepsia, gastroesophageal reflux disease, constipation, palpitations, rash"
81,CERDELGA,warnings and precautions,"ECG Changes, Cardiac Arrhythmias, prolongation of the PR interval, prolongation of the QTc interval, prolongation of the QRS interval, congestive heart failure, acute myocardial infarction, bradycardia, heart block, ventricular arrhythmia, long QT syndrome"
82,GADAVIST,adverse reactions,"Nephrogenic Systemic Fibrosis (NSF), Hypersensitivity reactions, headache, nausea, dizziness, Dysgeusia, Feeling Hot, Injection site reactions, Vomiting, Rash, Pruritus, Erythema, Hypersensitivity/Anaphylactoid, Dyspnea, Paresthesia, loss of consciousness, convulsion, parosmia, tachycardia, palpitation, dry mouth, malaise, feeling cold, Cardiac arrest, anaphylactic shock, circulatory collapse, respiratory arrest, pulmonary edema, bronchospasm, cyanosis, oropharyngeal swelling, laryngeal edema, blood pressure increased, chest pain, angioedema, conjunctivitis, hyperhidrosis, cough, sneezing, burning sensation, pallor, death"
83,GADAVIST,boxed warnings,"Nephrogenic Systemic Fibrosis (NSF), fatal, debilitating fibrosis, skin fibrosis, muscle fibrosis, internal organ fibrosis, Chronic severe kidney disease, Acute kidney injury, reduced renal function, hypertension, diabetes, death"
84,GADAVIST,warnings and precautions,"Nephrogenic Systemic Fibrosis, impaired elimination of GBCAs, Anaphylactic reactions, hypersensitivity reactions, cardiovascular manifestations, respiratory manifestations, cutaneous manifestations, death, acute kidney injury, drug-induced kidney toxicity, NSF, fibrosis affecting the skin, fibrosis affecting muscle, fibrosis affecting internal organs, chronic renal impairment, dialysis, Extravasation, moderate irritation, Overestimation of Extent of Malignant Disease."
85,ZYKADIA,adverse reactions,"Severe or Persistent Gastrointestinal Toxicity, Hepatotoxicity, Interstitial Lung Disease, Pneumonitis, QT Interval Prolongation, Hyperglycemia, Bradycardia, Pancreatitis, diarrhea, nausea, elevated transaminases, vomiting, abdominal pain, fatigue, decreased appetite, constipation, convulsion, pneumonia, dyspnea, dehydration, respiratory failure, pneumothorax, gastric hemorrhage, general physical health deterioration, pulmonary tuberculosis, cardiac tamponade, sepsis, neuropathy, vision disorder, prolonged QT interval, Hemoglobin decreased, Alanine transaminase (ALT) increased, Aspartate transaminase (AST) increased, Creatinine increased, Glucose increased, Phosphate decreased, Lipase increased, Bilirubin (total) increased, death"
86,ZYKADIA,warnings and precautions,"diarrhea, nausea, vomiting, abdominal pain, hepatotoxicity, liver laboratory tests abnormalities, alanine aminotransferase elevation, aspartate aminotransferase elevation, total bilirubin elevation, jaundice, Interstitial Lung Disease (ILD), pneumonitis, QT Interval Prolongation, ventricular tachyarrhythmias, Torsade de pointes, sudden death, hyperglycemia, bradycardia, sinus bradycardia, pancreatitis, lipase elevation, amylase elevation, embryofetal toxicity, skeletal anomalies, death"
87,XALKORI,adverse reactions,"Hepatotoxicity, Interstitial Lung Disease, Pneumonitis, QT Interval Prolongation, Bradycardia, Severe Visual Loss, vision disorders, diarrhea, nausea, vomiting, constipation, edema, elevated transaminases, upper respiratory infection, decreased appetite, dysgeusia, dyspnea, pulmonary embolism, septic shock, acute respiratory failure, diabetic ketoacidosis, nausea, hepatotoxicity, ILD, Electrocardiogram QT prolonged, Vision disorder, Vomiting, Diarrhea, Constipation, Dyspepsia, Dysphagia, Abdominal pain, Pyrexia, Weight increased, Pain in extremity, Muscle spasm, Dizziness, Headache, fatigue, neuropathy, rash, renal cyst, syncope, pneumonia, arrhythmia, acute respiratory distress syndrome, respiratory failure, sepsis, hepatic failure, Hypophosphatemia, Neutropenia, Lymphopenia, ALT elevation, AST elevation, Hypokalemia, death"
88,XALKORI,warnings and precautions,"Hepatotoxicity, Fatal hepatotoxicity, Interstitial Lung Disease (ILD), Pneumonitis, QT Interval Prolongation, Bradycardia, Severe Visual Loss, Embryofetal Toxicity, death, Drug-induced hepatotoxicity, elevated transaminases, severe visual loss, optic atrophy, optic nerve disorder, embryotoxicity, fetotoxicity"
89,BEPREVE,adverse reactions,"mild taste following instillation, eye irritation, headache, nasopharyngitis, hypersensitivity reactions, itching, body rash, swelling of lips, swelling of tongue, swelling of throat"
90,BEPREVE,warnings and precautions,"contact lens-related irritation, eye is red"
91,EDARBI,adverse reactions,"diarrhea, hypotension, orthostatic hypotension, nausea, asthenia, fatigue, muscle spasm, dizziness, dizziness postural, cough, serum creatinine increases, low hemoglobin, low hematocrit, low RBC counts, abnormal platelet counts, abnormal WBC counts, rash, pruritus, angioedema"
92,EDARBI,boxed warnings,"fetal toxicity, injury, death"
93,EDARBI,warnings and precautions,"fetal toxicity, fetal renal function reduction, fetal and neonatal morbidity, death, oligohydramnios, fetal lung hypoplasia, skeletal deformations, skull hypoplasia, anuria, hypotension, renal failure, symptomatic hypotension, oliguria, progressive azotemia, acute renal failure, increases in serum creatinine, increases in blood urea nitrogen"
94,POTIGA,adverse reactions,"Retinal abnormalities, potential vision loss, urinary retention, skin discoloration, neuropsychiatric symptoms, dizziness, somnolence, QT interval effect, suicidal behavior, ideation, withdrawal seizures, fatigue, confusional state, vertigo, tremor, abnormal coordination, diplopia, disturbance in attention, memory impairment, asthenia, blurred vision, gait disturbance, aphasia, dysarthria, balance disorder, nausea, constipation, dyspepsia, influenza, weight increased, paresthesia, amnesia, dysphasia, anxiety, disorientation, psychotic disorder, dysuria, urinary hesitation, hematuria, chromaturia, increased appetite, hallucinations, myoclonus, peripheral edema, hypokinesia, dry mouth, dysphagia, hyperhidrosis, malaise, increased liver enzymes, rash, nystagmus, dyspnea, leukopenia, muscle spasms, alopecia, nephrolithiasis, syncope, neutropenia, thrombocytopenia, euphoric mood, renal colic, coma, encephalopathy"
95,POTIGA,boxed warnings,"retinal abnormalities, potential vision loss, damage to the photoreceptors, vision loss, abnormal visual acuity, decreased visual acuity, retinal pigmentary abnormalities, vision changes"
96,POTIGA,warnings and precautions,"urinary retention, urologic symptoms, skin discoloration, neuropsychiatric symptoms, confusional state, psychotic symptoms, hallucinations, dizziness, somnolence, QT prolongation, suicidal thoughts, behaviors, retinal abnormalities, potential vision loss, funduscopic features, retinal pigment dystrophies, damage to photoreceptors, vision loss, retinal pigmentary abnormalities, perivascular pigmentation, bone spicule pattern, retinal periphery, retinal pigment epithelium clumping, abnormal visual acuity, retinal dystrophy, electroretinogram abnormalities, electrooculogram abnormalities, abnormal fluorescein angiography, diminished sensitivity on visual field testing, hydronephrosis, renal function impairment, urinary hesitation, dysuria, skin abnormalities, systemic involvement, blue discoloration, grey-blue discoloration, brown discoloration, nail beds discoloration, lips discoloration, face discoloration, legs discoloration, palate discoloration, sclera discoloration, conjunctiva discoloration, mucous membrane discoloration, withdrawal seizures"
97,TUDORZA,adverse reactions,"Paradoxical bronchospasm, Worsening of narrow-angle glaucoma, Worsening of urinary retention, Immediate Hypersensitivity Reactions, headache, nasopharyngitis, cough, diarrhea, sinusitis, rhinitis, toothache, fall, vomiting, diabetes mellitus, dry mouth, 1st degree AV block, osteoarthritis, cardiac failure, cardio-respiratory arrest, anaphylaxis, angioedema, urticaria, rash, bronchospasm, itching, death"
98,TUDORZA,warnings and precautions,"paradoxical bronchospasm, worsening of narrow-angle glaucoma, worsening of urinary retention, immediate hypersensitivity reactions, angioedema, anaphylaxis, bronchospasm, urticaria, rash, itching, eye pain, discomfort, blurred vision, visual halos, colored images, red eyes, conjunctival congestion, corneal edema, difficulty passing urine, painful urination, swelling of the lips, tongue, throat"
99,PROMACTA,adverse reactions,"Hepatic Decompensation, Hepatotoxicity, Thrombotic/Thromboembolic Complications, Cataracts, nausea, diarrhea, upper respiratory tract infection, vomiting, increased ALT, myalgia, urinary tract infection, nasopharyngitis, rhinitis, anemia, pyrexia, fatigue, headache, decreased appetite, influenza-like illness, asthenia, insomnia, cough, pruritus, chills, alopecia, peripheral edema, hemorrhage, oropharyngeal pain, increased AST, pharyngitis, back pain, influenza, paresthesia, rash, blood alkaline phosphatase increased, dry mouth, hyperbilirubinemia, abdominal pain, toothache, vitamin D deficiency, dyspnea, dizziness, febrile neutropenia, ecchymosis, muscle spasms, transaminases increased, arthralgia, rhinorrhea, pain in extremity, Thrombotic microangiopathy, acute renal failure"
100,PROMACTA,boxed warnings,hepatic decompensation
101,PROMACTA,warnings and precautions,"Hepatotoxicity, liver function abnormalities, liver enzyme elevations, indirect hyperbilirubinemia, increased direct bilirubin, clinical symptoms of liver injury, hepatic decompensation, ascites, encephalopathy, thrombotic event, thromboembolic complication, venous event, arterial event, portal vein thrombosis (PVT), abdominal pain, nausea, vomiting, diarrhea, cataracts."
102,INLYTA,adverse reactions,"hypertension, arterial thromboembolic events, venous thromboembolic events, hemorrhage, cardiac failure, gastrointestinal perforation, fistula formation, thyroid dysfunction, wound healing complications, RPLS, proteinuria, elevation of liver enzymes, hepatic impairment, fetal development, diarrhea, fatigue, decreased appetite, nausea, dysphonia, palmar-plantar erythrodysesthesia syndrome, weight decreased, vomiting, asthenia, constipation, hypothyroidism, cough, mucosal inflammation, arthralgia, stomatitis, dyspnea, abdominal pain, headache, pain in extremity, rash, dysgeusia, dry skin, dyspepsia, pruritus, alopecia, erythema, dizziness, upper abdominal pain, myalgia, dehydration, epistaxis, anemia, hemorrhoids, hematuria, tinnitus, lipase increased, glossodynia, pulmonary embolism, rectal hemorrhage, hemoptysis, deep vein thrombosis, retinal-vein occlusion/thrombosis, polycythemia, transient ischemic attack, hemoglobin decreased, lymphocytes decreased, platelets decreased, white blood cells decreased, creatinine increased, bicarbonate decreased, hypocalcemia, ALP increased, hyperglycemia, amylase increased, ALT increased, AST increased, hypernatremia, hypoalbuminemia, hyperkalemia, hypoglycemia, hyponatremia, hypophosphatemia, hemoglobin increased, hypercalcemia"
103,INLYTA,warnings and precautions,"hypertension, hypertensive crisis, arterial thrombotic events, venous thrombotic events, hemorrhagic events, cardiac failure, gastrointestinal perforation, fistula, hypothyroidism, thyroid hormone replacement, Reversible Posterior Leukoencephalopathy Syndrome (RPLS), proteinuria, liver enzyme elevation, fetal harm, death"
104,NORTHERA,adverse reactions,"Supine Hypertension, Hyperpyrexia, Confusion, Ischemic Heart Disease, Arrhythmias, Congestive Heart Failure, Headache, Dizziness, Nausea, Hypertension, Fatigue, Increased Blood Pressure, Falls, Urinary Tract Infections, Syncope"
105,NORTHERA,boxed warnings,supine hypertension
106,NORTHERA,warnings and precautions,"supine hypertension, cardiovascular risk, hyperpyrexia, confusion, exacerbate symptoms, ischemic heart disease, arrhythmias, congestive heart failure, allergic reactions, neuroleptic malignant syndrome (NMS), fever, hyperthermia, muscle rigidity, involuntary movements, altered consciousness, mental status changes, FD&C Yellow No. 5 (tartrazine) sensitivity, bronchial asthma, aspirin hypersensitivity"
107,JARDIANCE,adverse reactions,"Hypotension, Impairment in Renal Function, Hypoglycemia, Genital Mycotic Infections, Urinary Tract Infections, Increased Low-Density Lipoprotein Cholesterol (LDL-C), Urinary tract infection, Female genital mycotic infections, Upper respiratory tract infection, Increased urination, Dyslipidemia, Arthralgia, Male genital mycotic infections, Nausea, Thirst, Volume Depletion, Increased Urination, Impairment in Renal Function, Hypoglycemia, Genital Mycotic Infections, Phimosis, Laboratory Tests, Increase in Low-Density Lipoprotein Cholesterol (LDL-C), Increase in Hematocrit"
108,JARDIANCE,warnings and precautions,"hypotension, renal impairment, hypoglycemia, genital mycotic infections, urinary tract infections, increased LDL-C"
109,FANAPT,adverse reactions,"dizziness, dry mouth, fatigue, nasal congestion, orthostatic hypotension, somnolence, tachycardia, weight increased, arthralgia, musculoskeletal stiffness, vision blurred, nausea, diarrhea, abdominal discomfort, nasopharyngitis, upper respiratory tract infection, extrapyramidal disorder, tremor, lethargy, ejaculation failure, dyspnea, rash, hypotension, akathisia, bradykinesia, dyskinesia, dystonia, parkinsonism, palpitations, arrhythmia, atrioventricular block first degree, cardiac failure, vertigo, tinnitus, hypothyroidism, conjunctivitis, dry eye, blepharitis, eyelid edema, eye swelling, lenticular opacities, cataract, hyperemia, gastritis, salivary hypersecretion, fecal incontinence, mouth ulceration, aphthous stomatitis, duodenal ulcer, hiatus hernia, hyperchlorhydria, lip ulceration, reflux esophagitis, stomatitis, edema, difficulty in walking, thirst, hyperthermia, cholelithiasis, weight decreased, hemoglobin decreased, neutrophil count increased, hematocrit decreased, increased appetite, dehydration, hypokalemia, fluid retention, myalgia, muscle spasms, torticollis, paresthesia, psychomotor hyperactivity, restlessness, amnesia, nystagmus, restless legs syndrome, aggression, delusion, hostility, libido decreased, paranoia, anorgasmia, confusional state, mania, catatonia, mood swings, panic attack, obsessive-compulsive disorder, bulimia nervosa, delirium, polydipsia psychogenic, impulse-control disorder, major depression, urinary incontinence, dysuria, pollakiuria, enuresis, nephrolithiasis, urinary retention, renal failure acute, erectile dysfunction, testicular pain, amenorrhea, breast pain, menstruation irregular, gynecomastia, menorrhagia, metrorrhagia, postmenopausal hemorrhage, prostatitis, epistaxis, asthma, rhinorrhea, sinus congestion, nasal dryness, dry throat, sleep apnea syndrome, dyspnea exertional, retrograde ejaculation"
110,FANAPT,boxed warnings,"increased mortality, death, dementia-related psychosis, cardiovascular events, heart failure, sudden death, infectious events, pneumonia"
111,FANAPT,warnings and precautions,"death, cerebrovascular-related adverse events, stroke, QT prolongation, arrhythmia, sudden death, Neuroleptic Malignant Syndrome, Tardive dyskinesia, Hyperglycemia, diabetes mellitus, polydipsia, polyuria, polyphagia, weakness, Dyslipidemia, Weight Gain, metabolic changes, cardiovascular risk, cerebrovascular risk, Seizures, Orthostatic hypotension, dizziness, tachycardia, syncope, Leukopenia, Neutropenia, Agranulocytosis, Suicide, Priapism, cognitive impairment, motor impairment, somnolence, sedation"
112,TANZEUM,adverse reactions,"Thyroid C-cell Tumors, Acute Pancreatitis, Hypoglycemia, Hypersensitivity Reactions, Renal Impairment, Upper respiratory tract infection, Diarrhea, Nausea, Injection site reaction, Cough, Back pain, Arthralgia, Sinusitis, Influenza, Vomiting, Gastroesophageal reflux disease, Dyspepsia, Constipation, Injection site hematoma, Injection site erythema, Injection site rash, Injection site hypersensitivity, Injection site hemorrhage, Injection site pruritus, Pneumonia, Atrial fibrillation, Atrial flutter, Appendicitis, Liver Enzyme Abnormalities, Alanine aminotransferase (ALT) increase, Gamma Glutamyltransferase (GGT) Increase, Heart Rate Increase"
113,TANZEUM,boxed warnings,"thyroid C-cell tumors, medullary thyroid carcinoma (MTC), Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), mass in the neck, dysphagia, dyspnea, persistent hoarseness"
114,TANZEUM,warnings and precautions,"Thyroid C-cell Tumors, Pancreatitis, Hypoglycemia, Hypersensitivity Reactions, Renal Impairment, Macrovascular Outcomes, Carcinogenicity, Thyroid C-cell adenomas, Thyroid C-cell carcinomas, Medullary Thyroid Carcinoma (MTC), Acute Pancreatitis, Serious Hypersensitivity Reaction, Pruritus, Rash, Dyspnea, Acute Renal Failure, Worsening of Chronic Renal Failure, Nausea, Vomiting, Diarrhea, Dehydration"
115,EYLEA,adverse reactions,"Endophthalmitis, retinal detachments, Increased intraocular pressure, Thromboembolic events, conjunctival hemorrhage, eye pain, cataract, vitreous floaters, vitreous detachment, Ocular hyperemia, Corneal epithelium defect, Detachment of the retinal pigment epithelium, Injection site pain, Foreign body sensation in eyes, Lacrimation increased, Vision blurred, Intraocular inflammation, Retinal pigment epithelium tear, Injection site hemorrhage, Eyelid edema, Corneal edema, hypersensitivity, retinal tear, death"
116,EYLEA,warnings and precautions,"endophthalmitis, retinal detachments, increases in intraocular pressure, arterial thromboembolic events, nonfatal stroke, nonfatal myocardial infarction, vascular death, death"
117,JEVTANA,adverse reactions,"Bone Marrow Suppression, Hypersensitivity Reactions, Gastrointestinal Adverse Reactions, Renal Failure, Embryo-Fetal Toxicity, neutropenia, anemia, leukopenia, thrombocytopenia, diarrhea, fatigue, nausea, vomiting, constipation, asthenia, abdominal pain, hematuria, back pain, anorexia, peripheral neuropathy, pyrexia, dyspnea, dysgeusia, cough, arthralgia, alopecia, infections, ventricular fibrillation, cerebral hemorrhage, febrile neutropenia, arrhythmia, dyspepsia, peripheral edema, mucosal inflammation, pain, urinary tract infection, weight decreased, dehydration, muscle spasms, dizziness, headache, dysuria, hypotension, sepsis, septic shock, increased AST, increased ALT, increased bilirubin, gastritis, intestinal obstruction, death"
118,JEVTANA,boxed warnings,"neutropenia, neutropenic deaths, death, hypersensitivity, generalized rash, erythema, hypotension, bronchospasm, severe hypersensitivity reactions"
119,JEVTANA,warnings and precautions,"Bone marrow suppression, neutropenia, febrile neutropenia, neutropenic infections, anemia, thrombocytopenia, pancytopenia, neutropenic deaths, sepsis, septic shock, hypersensitivity reactions, generalized rash/erythema, hypotension, bronchospasm, gastrointestinal disorders, nausea, vomiting, diarrhea, gastrointestinal hemorrhage, perforation, ileus, enterocolitis, neutropenic enterocolitis, abdominal pain, tenderness, fever, persistent constipation, renal failure, obstructive uropathy, hepatic impairment, embryo-fetal toxicity, embryotoxic, fetotoxic, abortifacient, death"
120,YERVOY,adverse reactions,"immune-mediated enterocolitis, immune-mediated hepatitis, immune-mediated dermatitis, immune-mediated neuropathies, immune-mediated endocrinopathies, ocular manifestations, fatigue, diarrhea, pruritus, rash, colitis, hepatotoxicity, dermatitis, neuropathy, endocrinopathy, hypopituitarism, adrenal insufficiency, pneumonitis, meningitis, nephritis, eosinophilia, pericarditis, urticaria, large intestinal ulcer, esophagitis, acute respiratory distress syndrome, renal failure, infusion reaction, Drug reaction with eosinophilia and systemic symptoms (DRESS syndrome), death"
121,YERVOY,boxed warnings,"enterocolitis, hepatitis, dermatitis, toxic epidermal necrolysis, neuropathy, endocrinopathy, death"
122,YERVOY,warnings and precautions,"severe immune-mediated reactions, fatal immune-mediated reactions, moderate immune-mediated adverse reactions, immune-mediated hepatitis, immune-mediated endocrinopathies, immune-mediated enterocolitis, severe enterocolitis, life-threatening enterocolitis, fatal enterocolitis, moderate enterocolitis, intestinal perforation, complications, severe enterocolitis, hospitalization, immune-mediated dermatitis, Stevens-Johnson syndrome, toxic epidermal necrolysis, rash complicated by full thickness dermal ulceration, necrotic dermatitis, bullous dermatitis, hemorrhagic dermatitis, severe dermatitis, moderate dermatitis, immune-mediated neuropathies, fatal Guillain-Barre syndrome, severe peripheral motor neuropathy, myasthenia gravis, Guillain-Barre syndrome, motor neuropathy, sensory neuropathy, unilateral weakness, bilateral weakness, sensory alterations, paresthesia, Guillain-Barre-like syndromes, severe neuropathy, moderate neuropathy, hypopituitarism, adrenal insufficiency, hypogonadism, hypothyroidism, severe endocrinopathies, moderate endocrinopathy, hyperthyroidism, Cushing's syndrome, hypophysitis, adrenal crisis, hyperthyroidism, nephritis, pneumonitis, meningitis, pericarditis, uveitis, iritis, hemolytic anemia, myocarditis, angiopathy, temporal arteritis, vasculitis, polymyalgia rheumatica, conjunctivitis, blepharitis, episcleritis, scleritis, leukocytoclastic vasculitis, erythema multiforme, psoriasis, pancreatitis, arthritis, autoimmune thyroiditis, sarcoidosis, neurosensory hypoacusis, autoimmune central neuropathy (encephalitis), myositis, polymyositis, ocular myositis, immune-mediated ocular disease, death"
123,FARXIGA,adverse reactions,"Hypotension, Impairment in Renal Function, Hypoglycemia, Genital Mycotic Infections, Increases in Low-Density Lipoprotein Cholesterol (LDL-C), Bladder Cancer, Nasopharyngitis, Urinary Tract Infections, Back Pain, Increased Urination, Male Genital Mycotic Infections, Nausea, Influenza, Dyslipidemia, Constipation, Discomfort with Urination, Pain in Extremity, Volume Depletion, Dehydration, Hypovolemia, Orthostatic Hypotension, Renal Failure, Blood Creatinine Increase, Bone Fractures, Hypersensitivity Reactions, Angioedema, Urticaria, Anaphylactic Reactions, Severe Cutaneous Adverse Reactions, Increase in Hematocrit, Increase in Serum Inorganic Phosphorus, Increase in Low-Density Lipoprotein Cholesterol"
124,FARXIGA,warnings and precautions,"hypotension, impairment in renal function, hypoglycemia, genital mycotic infections, increased LDL-C, bladder cancer"
125,PICATO,adverse reactions,"Ophthalmic Adverse Reaction, Hypersensitivity Reactions, local skin reactions, application site pain, application site pruritus, application site irritation, application site infection, periorbital edema, nasopharyngitis, headache, erythema, flaking/scaling, crusting, swelling, vesiculation/pustulation, erosion/ulceration, eyelid edema, eye pain, conjunctivitis, hypersensitivity, allergic contact dermatitis, herpes zoster, chemical conjunctivitis, corneal burn"
126,PICATO,warnings and precautions,"severe eye pain, chemical conjunctivitis, corneal burn, eyelid edema, eyelid ptosis, periorbital edema, local skin reactions, vesiculation/pustulation, erosion/ulceration, hypersensitivity reactions, anaphylaxis, allergic contact dermatitis, erythema, crusting, swelling"
127,PRISTIQ,adverse reactions,"Hypersensitivity, Suicidal Thoughts and Behaviors, Serotonin Syndrome, Elevated Blood Pressure, Abnormal Bleeding, Angle Closure Glaucoma, Activation of Mania/Hypomania, Discontinuation Syndrome, Seizure, Hyponatremia, Interstitial Lung Disease, Eosinophilic Pneumonia, nausea, dizziness, insomnia, hyperhidrosis, constipation, somnolence, decreased appetite, anxiety, specific male sexual function disorders, Blood pressure increased, Dry mouth, Vomiting, Fatigue, Chills, Feeling jittery, Decreased appetite, Tremor, Disturbance in attention, Insomnia, Nervousness, Abnormal dreams, Urinary hesitation, Yawning, Vision blurred, Mydriasis, Vertigo, Tinnitus, Dysgeusia, Hot flush, Anorgasmia, Libido decreased, Orgasm abnormal, Ejaculation delayed, Erectile dysfunction, Ejaculation disorder, Ejaculation failure, Sexual dysfunction, Tachycardia, Asthenia, Weight increased, liver function test abnormal, blood prolactin increased, Musculoskeletal stiffness, Syncope, convulsion, dystonia, Depersonalization, bruxism, Urinary retention, Rash, alopecia, photosensitivity reaction, angioedema, myocardial ischemia, myocardial infarction, coronary occlusion requiring revascularization, Lipid abnormalities, Proteinuria, Sustained hypertension, Orthostatic hypotension, Stevens-Johnson syndrome"
128,PRISTIQ,boxed warnings,"suicidal thoughts, suicidal behaviors, worsening of depression, emergence of suicidal thoughts, emergence of suicidal behaviors"
129,PRISTIQ,warnings and precautions,"clinical worsening, suicide risk, suicidal thoughts, suicidal behaviors, suicidality, unusual changes in behavior, serotonin syndrome, elevated blood pressure, hypertension, abnormal bleeding, bleeding events, coagulation, angle closure glaucoma, activation of mania, hypomania, mania, discontinuation syndrome, seizure, hyponatremia, interstitial lung disease, eosinophilic pneumonia, mental status changes, agitation, hallucinations, delirium, coma, autonomic instability, tachycardia, labile blood pressure, dizziness, diaphoresis, flushing, hyperthermia, neuromuscular symptoms, tremor, rigidity, myoclonus, hyperreflexia, incoordination, gastrointestinal symptoms, nausea, vomiting, diarrhea, anxiety, panic attacks, insomnia, irritability, hostility, aggressiveness, impulsivity, akathisia, psychomotor restlessness, ecchymosis, hematoma, epistaxis, petechiae, hemorrhages, dysphoric mood, sensory disturbances, paresthesia, electric shock sensations, confusion, headache, lethargy, emotional lability, tinnitus, difficulty concentrating, memory impairment, confusion, weakness, unsteadiness, hallucination, syncope, respiratory arrest, death"
130,STRIBILD,adverse reactions,"Lactic Acidosis, Severe Hepatomegaly with Steatosis, Severe Acute Exacerbations of Hepatitis B, New Onset or Worsening Renal Impairment, Bone Effects of Tenofovir DF, Immune Reconstitution Syndrome, nausea, diarrhea, Ocular icterus, Flatulence, Fatigue, Jaundice, Somnolence, Headache, Dizziness, Insomnia, Abnormal dreams, Rash, suicidal ideation, suicide attempt, depression, abdominal pain, dyspepsia, vomiting, fever, pain, nasopharyngitis, pneumonia, sinusitis, upper respiratory tract infection, arthralgia, back pain, myalgia, paresthesia, peripheral neuropathy, peripheral neuritis, neuropathy, anxiety, increased cough, rhinitis, Skin discoloration, hyperpigmentation, Proteinuria, increased serum creatinine, decreased estimated creatinine clearance, renal glomerular function, AST elevation, ALT elevation, Amylase elevation, Creatine Kinase elevation, Hematuria, Bone Mineral Density decrease, bone fractures, allergic reaction, angioedema, lactic acidosis, hypokalemia, hypophosphatemia, dyspnea, pancreatitis, increased amylase, hepatic steatosis, hepatitis, increased liver enzymes, rash, rhabdomyolysis, osteomalacia, muscular weakness, myopathy, acute renal failure, renal failure, acute tubular necrosis, Fanconi syndrome, proximal renal tubulopathy, interstitial nephritis, nephrogenic diabetes insipidus, renal insufficiency, increased creatinine, proteinuria, polyuria, asthenia."
131,STRIBILD,boxed warnings,"lactic acidosis, severe hepatomegaly with steatosis, fatal cases, severe acute exacerbations of hepatitis B, death"
132,STRIBILD,warnings and precautions,"acute renal failure, Fanconi syndrome, renal impairment, bone mineral density (BMD) decrease, redistribution/accumulation of body fat, immune reconstitution syndrome, lactic acidosis, severe hepatomegaly with steatosis, death, severe acute exacerbations of hepatitis B, liver decompensation, liver failure, proximal renal tubulopathy, bone pain, pain in extremities, fractures, muscular pain, weakness, osteomalacia, arthralgias, central obesity, dorsocervical fat enlargement (buffalo hump), peripheral wasting, facial wasting, breast enlargement, ""cushingoid appearance"", inflammatory response, Mycobacterium avium infection, cytomegalovirus, Pneumocystis jirovecii pneumonia (PCP), tuberculosis, autoimmune disorders, Graves' disease, polymyositis, Guillain-Barre syndrome"
133,NULOJIX,adverse reactions,"PTLD, CNS PTLD, malignancies, serious infections, JC virus-associated PML, polyoma virus nephropathy, anemia, diarrhea, urinary tract infection, peripheral edema, constipation, hypertension, pyrexia, graft dysfunction, cough, nausea, vomiting, headache, hypokalemia, hyperkalemia, leukopenia, cytomegalovirus infection, complications of transplanted kidney, non-melanoma skin cancer, bacterial infections, mycobacterial infections, viral infections, fungal infections, tuberculosis, herpes infections, cryptococcal meningitis, Chagas encephalitis, cerebral aspergillosis, West Nile encephalitis, infusion reactions, hypotension, proteinuria, immunogenicity, new-onset diabetes after transplantation (NODAT), dyslipidemia, infections and infestations, upper respiratory infection, nasopharyngitis, influenza, bronchitis, abdominal pain, hypophosphatemia, dyslipidemia, hyperglycemia, hypocalcemia, hypercholesterolemia, hypomagnesemia, hyperuricemia, hematuria, dysuria, renal tubular necrosis, hypotension, dyspnea, blood creatinine increased, arthralgia, back pain, dizziness, tremor, acne, insomnia, anxiety, Guillain-Barre syndrome, stomatitis, aphthous stomatitis, chronic allograft nephropathy, wound dehiscence, arteriovenous fistula thrombosis, neutropenia, renal impairment, acute renal failure, renal artery stenosis, urinary incontinence, hydronephrosis, hematoma, lymphocele, musculoskeletal pain, alopecia, hyperhidrosis, atrial fibrillation, death (due to fatal cases of PML)."
134,NULOJIX,boxed warnings,"post-transplant lymphoproliferative disorder (PTLD), central nervous system involvement, malignancies, serious infections, increased susceptibility to infection, graft loss, death"
135,NULOJIX,warnings and precautions,"Post-Transplant Lymphoproliferative Disorder (PTLD), new or worsening neurological signs, cognitive signs, behavioral signs, other malignancies, increased risk of bacterial infections, viral infections, fungal infections, protozoal infections, opportunistic infections, tuberculosis, Polyoma virus-associated nephropathy (PVAN), kidney graft loss, Progressive Multifocal Leukoencephalopathy (PML), JC virus infection, cytomegalovirus (CMV) infection, herpes infection, Pneumocystis jiroveci infection, BK virus infection, acute rejection, graft loss, death"
136,LUMIZYME,adverse reactions,"hypersensitivity reactions, anaphylaxis, rash, pyrexia, flushing/feeling hot, urticaria, headache, hyperhidrosis, nausea, cough, decreased oxygen saturation, tachycardia, tachypnea, chest discomfort, dizziness, muscle twitching, agitation, cyanosis, erythema, hypertension/increased blood pressure, pallor, rigors, tremor, vomiting, fatigue, myalgia, acute cardiorespiratory failure, livedo reticularis, irritability, retching, increased lacrimation, ventricular extrasystoles, nodal rhythm, rales, respiratory tract irritation, cold sweat, angioedema, throat tightness, supraventricular tachycardia, paresthesia, local swelling, diarrhea, pruritus, edema peripheral, rash papular, anaphylactic shock, respiratory failure, respiratory arrest, cardiac arrest, hypoxia, dyspnea, wheezing, convulsions, peripheral coldness, restlessness, nervousness, back pain, stridor, pharyngeal edema, abdominal pain, apnea, muscle spasm, conjunctivitis, hyperparathyroidism, proteinuria, nephrotic syndrome, membranous glomerulonephritis, necrotizing skin lesions, death"
137,LUMIZYME,boxed warnings,"anaphylaxis, hypersensitivity reactions, immune-mediated reactions, cardiorespiratory failure, respiratory distress, hypoxia, apnea, dyspnea, bradycardia, tachycardia, bronchospasm, throat tightness, hypotension, angioedema, tongue swelling, lip swelling, periorbital edema, face edema, urticaria, proteinuria, nephrotic syndrome, necrotizing skin lesions, fluid overload, acute exacerbation of cardiac compromise, acute exacerbation of respiratory compromise"
138,LUMIZYME,warnings and precautions,"anaphylaxis, hypersensitivity reactions, anaphylactic shock, cardiac arrest, respiratory arrest, respiratory distress, hypoxia, apnea, dyspnea, bradycardia, tachycardia, bronchospasm, throat tightness, hypotension, angioedema, tongue swelling, lip swelling, periorbital edema, face edema, urticaria, chest discomfort, chest pain, wheezing, tachypnea, cyanosis, decreased oxygen saturation, convulsions, pruritus, rash, hyperhidrosis, nausea, dizziness, hypertension, increased blood pressure, flushing, feeling hot, erythema, pyrexia, pallor, peripheral coldness, restlessness, nervousness, headache, back pain, paresthesia, immune-mediated reactions, necrotizing skin lesions, type III immune-mediated reactions, inflammatory arthropathy, pyrexia, elevated erythrocyte sedimentation rate, nephrotic syndrome, membranous glomerulonephritis, immune complex deposition, acute cardiorespiratory failure, cardiac hypertrophy, fluid overload, cardiac arrhythmia, sudden cardiac death, general anesthesia complications, ventricular arrhythmias, bradycardia, cardiac resuscitation, defibrillation, antibody development, reduced clinical efficacy, loss of motor function, ventilator dependence, death"
139,EOVIST,adverse reactions,"Nephrogenic systemic fibrosis (NSF), Hypersensitivity reactions, nausea, headache, feeling hot, dizziness, back pain, vomiting, blood pressure increased, injection site reactions, pain, burning, coldness, extravasation, irritation, dysgeusia, paresthesia, flushing, parosmia, pruritus, generalized pruritus, eye pruritus, rash, respiratory disorders, dyspnea, respiratory distress, fatigue, chest pain, vertigo, dry mouth, chills, feeling abnormal, tremor, akathisia, bundle branch block, palpitation, oral discomfort, salivary hypersecretion, maculopapular rash, hyperhidrosis, discomfort, malaise, elevation of serum iron values, elevation of serum bilirubin, anaphylactic shock, hypotension, pharyngolaryngeal edema, urticaria, face edema, rhinitis, conjunctivitis, abdominal pain, hypoesthesia, sneezing, cough, pallor, tachycardia, restlessness"
140,EOVIST,boxed warnings,"Nephrogenic Systemic Fibrosis (NSF), fatal, debilitating fibrosis, skin fibrosis, muscle fibrosis, internal organ fibrosis, chronic severe kidney disease, acute kidney injury, reduced renal function, death"
141,EOVIST,warnings and precautions,"Nephrogenic Systemic Fibrosis (NSF), impaired elimination of GBCAs, higher than recommended dosing, repeated dosing, Hypersensitivity, anaphylactoid reactions, hypersensitivity reactions, cardiovascular manifestations, respiratory manifestations, cutaneous manifestations, severe reactions, shock, emergency cardiorespiratory support, chronic severe kidney disease, acute kidney injury, debilitating fibrosis, skin fibrosis, muscle fibrosis, internal organ fibrosis, death, rapid decrease in kidney function, surgery-related kidney injury, severe infection-related kidney injury, injury-related kidney injury, drug-induced kidney toxicity, chronically reduced renal function, diabetes mellitus, chronic hypertension, Anaphylactic reactions, allergic disorders, bronchial asthma, trained personnel for resuscitation, delayed reactions, Acute Kidney Injury, dialysis, dual excretory pathways, Extravasation, Injection Site Reactions, local tissue reactions, myocyte necrosis, inflammation, Interference with Laboratory Tests, falsely high or low serum iron values, Interference with Visualization of Liver Lesions, severe renal failure, severe hepatic failure, elevated serum ferritin levels, high serum bilirubin, reduced hepatic contrast."
142,BELEODAQ,adverse reactions,"Hematologic Toxicity, Infection, Hepatotoxicity, Tumor Lysis Syndrome, Gastrointestinal Toxicity, nausea, fatigue, pyrexia, anemia, vomiting, constipation, diarrhea, dyspnea, rash, peripheral edema, cough, thrombocytopenia, pruritus, chills, increased blood lactate dehydrogenase, decreased appetite, headache, infusion site pain, hypokalemia, prolonged QT, abdominal pain, hypotension, phlebitis, dizziness, pneumonia, increased creatinine, multi-organ failure, death, hepatic failure, ventricular fibrillation, febrile neutropenia"
143,BELEODAQ,warnings and precautions,"thrombocytopenia, leukopenia, neutropenia, lymphopenia, anemia, infection, serious infections, fatal infections, pneumonia, sepsis, hepatotoxicity, liver function test abnormalities, tumor lysis syndrome, nausea, vomiting, diarrhea, embryo-fetal toxicity, fetal harm, teratogenicity, embryo-fetal lethality, death"
144,VICTRELIS,adverse reactions,"fatigue, anemia, nausea, headache, dysgeusia, neutropenia, pancytopenia, hypersensitivity, chills, asthenia, decreased appetite, arthralgia, dizziness, insomnia, irritability, dyspnea exertional, alopecia, dry skin, rash, dry mouth, diarrhea, vomiting, agranulocytosis, thrombocytopenia, mouth ulceration, stomatitis, pneumonia, sepsis, angioedema, urticaria, drug rash with eosinophilia and systemic symptoms (DRESS) syndrome, exfoliative rash, exfoliative dermatitis, Stevens-Johnson syndrome, toxic skin eruption, toxicoderma"
145,VICTRELIS,warnings and precautions,"Embryofetal Toxicity, birth defects, fetal death, death, Anemia, decrease in hemoglobin concentrations, Neutropenia, worsening of neutropenia, Hypersensitivity, acute hypersensitivity reactions, urticaria, angioedema, Pancytopenia, thromboembolic events, pulmonary embolism, acute myocardial infarction, cerebrovascular accident, deep vein thrombosis, dyspnea, exertional dyspnea, dizziness, syncope, severe or life-threatening infections, life-threatening neutropenia"
146,VIMIZIM,adverse reactions,"anaphylaxis, hypersensitivity reactions, pyrexia, vomiting, headache, nausea, abdominal pain, chills, fatigue, immunogenicity, anti-drug antibodies, neutralizing antibodies"
147,VIMIZIM,boxed warnings,"anaphylaxis, cough, erythema, throat tightness, urticaria, flushing, cyanosis, hypotension, rash, dyspnea, chest discomfort, gastrointestinal symptoms, nausea, abdominal pain, retching, vomiting, hypersensitivity reactions, acute respiratory illness, serious acute exacerbation, respiratory compromise"
148,VIMIZIM,warnings and precautions,"anaphylaxis, hypersensitivity reactions, life-threatening anaphylaxis, severe hypersensitivity reactions, cough, erythema, throat tightness, urticaria, flushing, cyanosis, hypotension, rash, dyspnea, chest discomfort, gastrointestinal symptoms, nausea, abdominal pain, retching, vomiting, peripheral edema, acute respiratory complications, sleep apnea, spinal or cervical cord compression, back pain, paralysis, urinary incontinence, fecal incontinence, death"
149,SIRTURO,adverse reactions,"Increased mortality, QT Prolongation, Hepatotoxicity, Drug Interactions, nausea, arthralgia, headache, hemoptysis, chest pain, anorexia, Transaminases Increased, Rash, Blood Amylase Increased, death"
150,SIRTURO,boxed warnings,"Increased mortality, death, QT prolongation, significant ventricular arrhythmia"
151,SIRTURO,warnings and precautions,"QT prolongation, significant ventricular arrhythmia, QTcF interval > 500 ms, Hepatotoxicity, liver injury, Increased Mortality, death, ventricular arrhythmias, myocardial infarction, Torsade de Pointes, congenital long QT syndrome, hypothyroidism, bradyarrhythmias, uncompensated heart failure, serum calcium below lower limits of normal, serum magnesium below lower limits of normal, serum potassium below lower limits of normal, Clinically significant ventricular arrhythmia, syncope, hepatic-related adverse reactions, fatigue, anorexia, nausea, jaundice, dark urine, liver tenderness, hepatomegaly, ALT elevation, AST elevation, alkaline phosphatase elevation, bilirubin elevation, aminotransferase elevations with total bilirubin elevation greater than two times the upper limit of normal, aminotransferase elevations greater than eight times the upper limit of normal, aminotransferase elevations greater than five times the upper limit of normal and persist beyond two weeks"
152,NEURACEQ,adverse reactions,"erythema, irritation, pain, injection site reaction, adverse drug reactions, adverse reactions, injection site erythema, injection site irritation, injection site pain"
153,NEURACEQ,warnings and precautions,"Image interpretation errors, false positives, radiation exposure, risk for image misinterpretation, errors, severe brain atrophy, motion artifacts, image distortion, increased risk of cancer, unintentional radiation exposure"
154,COMETRIQ,adverse reactions,"Perforations, Fistula, Hemorrhage, Thromboembolic Events, Wound Complications, Hypertension, Osteonecrosis of the Jaw, Palmar-plantar erythrodysesthesia syndrome, Proteinuria, Reversible Posterior Leukoencephalopathy Syndrome, Diarrhea, Stomatitis, Decreased weight, Decreased appetite, Nausea, Fatigue, Oral pain, Hair color changes, Dysgeusia, Abdominal pain, Constipation, Increased AST, Increased ALT, Lymphopenia, Increased alkaline phosphatase, Hypocalcemia, Neutropenia, Thrombocytopenia, Hypophosphatemia, Hyperbilirubinemia, Asthenia, Dehydration, Arthralgia, Muscle spasms, Musculoskeletal chest pain, Headache, Dizziness, Paresthesia, Peripheral sensory neuropathy, Peripheral neuropathy, Anxiety, Dysphonia, Rash, Dry skin, Alopecia, Erythema, Hyperkeratosis, Hypotension, Vomiting, Dysphagia, Dyspepsia, Hemorrhoids, Hypomagnesemia, Hypokalemia, Hyponatremia, Pneumonia, Septicemia, Cardiac arrest, Respiratory failure, death."
155,COMETRIQ,boxed warnings,"Gastrointestinal perforations, fistula formation, hemorrhage, hemoptysis, gastrointestinal hemorrhage, severe hemorrhage, fatal hemorrhage, death"
156,COMETRIQ,warnings and precautions,"myocardial infarction, cerebral infarction, arterial thromboembolic events, dehiscence, wound complications, hypertensive crisis, osteonecrosis of the jaw, Palmar-plantar Erythrodysesthesia syndrome, PPES, Proteinuria, nephrotic syndrome, Reversible posterior leukoencephalopathy syndrome, RPLS, Gastrointestinal perforations, GI perforations, fistulas, GI fistula, tracheal/esophageal fistulas, Hemorrhage, venous thromboembolism, arterial thromboembolism, treatment-emergent hypertension, jaw pain, osteomyelitis, osteitis, bone erosion, tooth or periodontal infection, toothache, gingival ulceration, slow healing of the mouth or jaw, seizures, headache, visual disturbances, confusion, altered mental function, embryolethal, skeletal variations, visceral variations, malformations, death"
157,AFINITOR,adverse reactions,"Non-infectious pneumonitis, infections, angioedema, oral ulceration, renal failure, impaired wound healing, stomatitis, rash, fatigue, diarrhea, edema, abdominal pain, nausea, fever, asthenia, cough, headache, decreased appetite, hyperglycemia, dyspnea, pneumonitis, hypercholesterolemia, anemia, leukopenia, thrombocytopenia, lymphopenia, increased aspartate transaminase (AST), increased alanine transaminase (ALT), hypertriglyceridemia, lymphopenia, hyperglycemia, anemia, decreased potassium, increased AST, increased ALT, thrombocytopenia, death, mouth ulceration, aphthous stomatitis, glossodynia, gingival pain, glossitis, lip ulceration, nasopharyngitis, urinary tract infection, upper respiratory tract infection, pneumonia, bronchitis, cystitis, sinusitis, candidiasis, sepsis, hepatitis C, pneumonitis, interstitial lung disease, lung infiltration, pulmonary fibrosis, weight decreased, hyperglycemia, arthralgia, back pain, pain in extremity, dysgeusia, insomnia, fatigue, peripheral edema, pyrexia, asthenia, infections, weight decreased, hyperglycemia, musculoskeletal and connective tissue disorders, arthralgia, back pain, pain in extremity, nervous system disorders, dysgeusia, headache, psychiatric disorders, insomnia, cough, dyspnea, epistaxis, pneumonitis, skin and subcutaneous tissue disorders, rash, pruritus, alopecia, vascular disorders, hot flush, hemoglobin decreased, WBC decreased, platelets decreased, lymphocytes decreased, neutrophils decreased, glucose increased, cholesterol increased, aspartate transaminase (AST) increased, alanine transaminase (ALT) increased, triglycerides increased, albumin decreased, potassium decreased, creatinine increased, abdominal pain, nausea, vomiting, constipation, dry mouth, fatigue/malaise, edema (general and peripheral), fever, asthenia, nasopharyngitis/rhinitis/URI, urinary tract infection, weight decreased, diabetes mellitus, muscle spasms, headache/migraine, dizziness, cough/productive cough, epistaxis, dyspnea/dyspnea exertional, pneumonitis, oropharyngeal pain, nail disorders, pruritus/pruritus generalized, dry skin/xeroderma, hypertension, irregular menstruation, hemoglobin decreased, lymphocytes decreased, platelets decreased, WBC decreased, neutrophils decreased, alkaline phosphatase increased, glucose (fasting) increased, cholesterol increased, bicarbonate decreased, aspartate transaminase (AST) increased, alanine transaminase (ALT) increased, phosphate decreased, triglycerides increased, calcium decreased, potassium decreased, creatinine increased, sodium decreased, albumin decreased, bilirubin increased, potassium increased, stomatitis, asthenia, fatigue, cough, diarrhea, infections, dyspnea, dehydration, pneumonitis, abdominal pain, asthenia, anemia, hypercholesterolemia, hypertriglyceridemia, hyperglycemia, lymphopenia, increased creatinine, hypophosphatemia, hypercholesterolemia, abdominal pain, dry mouth, hemorrhoids, dysphagia, impaired wound healing, pleural effusion, pharyngolaryngeal pain, rhinorrhea, hand-foot syndrome, nail disorder, erythema, onychoclasis, skin lesion, acneiform dermatitis, angioedema, exacerbation of pre-existing diabetes mellitus, new onset of diabetes mellitus, insomnia, dizziness, paresthesia, eyelid edema, conjunctivitis, hypertension, deep vein thrombosis, renal failure, tachycardia, congestive cardiac failure, jaw pain, hemorrhage, amenorrhea, menorrhagia, menstrual irregularities, vaginal hemorrhage, epistaxis, decreased appetite, otitis media, depression, abnormal taste, increased blood luteinizing hormone (LH) levels, increased blood follicle stimulating hormone (FSH) levels, hypersensitivity, ovarian cyst, pneumonitis, angioedema, elevated partial thromboplastin time, neutropenia, elevated aspartate transaminase (AST), hypertriglyceridemia, elevated alanine transaminase (ALT), hypophosphatemia, cellulitis, hyperglycemia, elevated creatinine, acute pancreatitis, cholecystitis, cholelithiasis, arterial thrombotic events, reflex sympathetic dystrophy."
158,AFINITOR,warnings and precautions,"non-infectious pneumonitis, fatal cases, infections, fatal infections, angioedema, oral ulceration, mouth ulcers, stomatitis, oral mucositis, renal failure, acute renal failure, fatal outcome, impaired wound healing, wound-related complications, wound dehiscence, wound infection, incisional hernia, lymphocele, seroma, laboratory test alterations, serum creatinine elevations, urinary protein elevations, blood glucose elevations, lipid elevations, hemoglobin decreases, neutrophils decreases, platelets decreases, vaccinations, embryo-fetal toxicity, fetal harm, death"
159,BREO,adverse reactions,"asthma-related death, Candida albicans infection, increased risk of pneumonia in COPD, immunosuppression, hypercorticism, adrenal suppression, reduction in bone mineral density, nasopharyngitis, upper respiratory tract infection, headache, oral candidiasis, bronchitis, sinusitis, oropharyngeal pain, dysphonia, cough, back pain, pneumonia, arthralgia, influenza, pharyngitis, pyrexia, viral respiratory tract infection, extrasystoles, upper abdominal pain, respiratory tract infection, allergic rhinitis, rhinitis, supraventricular extrasystoles, ventricular extrasystoles, acute sinusitis, palpitations, tachycardia, hypersensitivity reactions, anaphylaxis, angioedema, rash, urticaria, muscle spasms, tremor, nervousness, death"
160,BREO,boxed warnings,"asthma-related death, increase in asthma-related deaths, asthma-related hospitalization, death"
161,BREO,warnings and precautions,"asthma-related death, asthma-related hospitalizations, overdose, Candida albicans infection, pneumonia, worsening of infections, tuberculosis, fungal infections, bacterial infections, viral infections, parasitic infections, ocular herpes simplex, impaired adrenal function, hypercorticism, adrenal suppression, paradoxical bronchospasm, cardiovascular disorders, decrease in bone mineral density, glaucoma, cataracts, convulsive disorders, thyrotoxicosis, diabetes mellitus, ketoacidosis, hypokalemia, hyperglycemia, death"
162,FIRAZYR,adverse reactions,"injection site reactions, pyrexia, transaminase increase, dizziness, rash, nausea, headache"
163,FIRAZYR,warnings and precautions,"laryngeal attacks, airway obstruction"
164,INVOKANA,adverse reactions,"Hypotension, Impairment in Renal Function, Hyperkalemia, Hypoglycemia, Genital Mycotic Infections, Hypersensitivity Reactions, Bone Fracture, Increases in Low-Density Lipoprotein (LDL-C), female genital mycotic infections, urinary tract infection, increased urination, male genital mycotic infections, vulvovaginal pruritus, thirst, constipation, nausea, abdominal pain, fatigue, loss of strength or energy (asthenia), pancreatitis, erythema, rash, pruritus, urticaria, angioedema, photosensitivity reaction, polymorphic light eruption, sunburn, volume depletion-related adverse reactions (e.g., hypotension, postural dizziness, orthostatic hypotension, syncope, dehydration), falls, increased blood creatinine, decreased glomerular filtration rate, renal impairment, acute renal failure, vulvovaginal mycotic infection, vulvovaginal candidiasis, vulvovaginitis, candidal balanitis, balanoposthitis, phimosis, severe hypoglycemia, increases in serum potassium, increases in serum magnesium, increases in serum phosphate, increases in non-High-Density Lipoprotein Cholesterol (non-HDL-C), increases in hemoglobin, decreases in Bone Mineral Density (BMD)."
165,INVOKANA,warnings and precautions,"hypotension, renal impairment, hyperkalemia, hypoglycemia, genital mycotic infections, hypersensitivity reactions, bone fracture, increased LDL-C"
166,VORAXAZE,adverse reactions,"Serious allergic reactions, anaphylactic reactions, paraesthesias, flushing, nausea, vomiting, hypotension, headache, myelosuppression, mucositis, acute hepatitis, renal dysfunction, renal failure, blurred vision, diarrhea, hypersensitivity, hypertension, rash, throat irritation, throat tightness, tremor, death"
167,VORAXAZE,warnings and precautions,"Serious allergic reactions, anaphylactic reactions, death"
168,NESINA,adverse reactions,"nasopharyngitis, headache, upper respiratory tract infection, pancreatitis, hypersensitivity reactions, serum sickness, hypoglycemia, anaphylaxis, angioedema, rash, urticaria, severe cutaneous adverse reactions, Stevens-Johnson syndrome, hepatic enzyme elevations, fulminant hepatic failure, severe and disabling arthralgia, acute pancreatitis"
169,NESINA,warnings and precautions,"acute pancreatitis, hypersensitivity reactions, anaphylaxis, angioedema, severe cutaneous adverse reactions, Stevens-Johnson syndrome, hepatic failure, death, hypoglycemia, severe and disabling arthralgia, liver injury, liver enzyme elevations, fatigue, anorexia, right upper abdominal discomfort, dark urine, jaundice"
170,GILENYA,adverse reactions,"Bradyarrhythmia, Atrioventricular Blocks, Infections, Progressive multifocal leukoencephalopathy, Macular Edema, Posterior Reversible Encephalopathy Syndrome, Respiratory Effects, Liver Injury, Headache, Liver transaminase elevation, Diarrhea, Cough, Influenza, Sinusitis, Back pain, Abdominal pain, Pain in extremity, Serum transaminase elevations, Basal cell carcinoma, Bronchitis, Herpes zoster, Tinea versicolor, Bradycardia, Migraine, Nausea, Asthenia, Alopecia, Actinic keratosis, Blood triglycerides increased, Dyspnea, Vision blurred, Hypertension, Lymphopenia, Leukopenia, Skin papilloma, Dizziness, Pneumonia, Eczema, Pruritus, Ischemic strokes, Hemorrhagic strokes, Peripheral arterial occlusive disease, Lymphoma"
171,GILENYA,warnings and precautions,"Bradycardia, atrioventricular conduction, infections, progressive multifocal leukoencephalopathy (PML), macular edema, posterior reversible encephalopathy syndrome (PRES), decrease in pulmonary function tests (PFT), liver injury, blood pressure (BP) increase, bradyarrhythmia, atrioventricular blocks, reduction in heart rate, symptomatic bradycardia, hypotension, dizziness, fatigue, palpitations, chest pain, first-degree AV block, second-degree AV block, Mobitz Types I (Wenckebach), 2:1 AV blocks, third-degree AV block, AV block with junctional escape, transient asystole, unexplained death, syncope, herpes zoster, influenza, sinusitis, pneumonia, herpes viral infections, disseminated primary herpes zoster, herpes simplex encephalitis, disseminated varicella zoster, herpes simplex infections, encephalitis, multiorgan failure, cryptococcal infections, cryptococcal meningitis, varicella zoster virus, JC virus, visual disturbances, forced expiratory volume over 1 second (FEV1) reduction, diffusion lung capacity for carbon monoxide (DLCO) reduction, dyspnea, elevation of liver transaminases, nausea, vomiting, abdominal pain, anorexia, jaundice, dark urine, fetal harm, hypertension, immune system effects, death."
172,HALAVEN,adverse reactions,"neutropenia, anemia, asthenia/fatigue, alopecia, peripheral neuropathy, nausea, constipation, febrile neutropenia, mucosal inflammation, pyrexia, diarrhea, vomiting, arthralgia/myalgia, back pain, bone pain, pain in extremity, weight decreased, anorexia, cough, dyspnea, urinary tract infection, cytopenias, thrombocytopenia, peripheral motor neuropathy, liver function test abnormalities, increased lacrimation, dyspepsia, abdominal pain, stomatitis, dry mouth, peripheral edema, upper respiratory tract infection, hypokalemia, muscle spasms, muscular weakness, dysgeusia, dizziness, insomnia, depression, rash, lymphopenia, pancreatitis, hepatotoxicity, drug hypersensitivity, pneumonia, sepsis/neutropenic sepsis, hypomagnesemia, dehydration, interstitial lung disease, pruritus, death"
173,HALAVEN,warnings and precautions,"Neutropenia, Peripheral Neuropathy, Embryo-Fetal Toxicity, QT Prolongation, Severe neutropenia, Grade 4 neutropenia, Febrile neutropenia, Grade 3 peripheral neuropathy, Grade 4 peripheral neuropathy, Peripheral motor neuropathy, Peripheral sensory neuropathy, Teratogenicity, Congestive heart failure, Bradyarrhythmias, Hypokalemia, Hypomagnesemia, Congenital long QT syndrome"
174,INTELENCE,adverse reactions,"Severe skin reactions, hypersensitivity reactions, rash, peripheral neuropathy, diarrhea, myocardial infarction, angina pectoris, atrial fibrillation, vertigo, blurred vision, gastroesophageal reflux disease, flatulence, gastritis, abdominal distension, pancreatitis, constipation, dry mouth, hematemesis, retching, stomatitis, sluggishness, hemolytic anemia, hepatic failure, hepatomegaly, cytolytic hepatitis, hepatic steatosis, hepatitis, drug hypersensitivity, immune reconstitution syndrome, diabetes mellitus, anorexia, dyslipidemia, paraesthesia, somnolence, convulsion, hypoesthesia, amnesia, syncope, disturbance in attention, hypersomnia, tremor, anxiety, sleep disorders, abnormal dreams, confusional state, disorientation, nervousness, nightmares, acute renal failure, gynecomastia, exertional dyspnea, bronchospasm, night sweats, lipohypertrophy, prurigo, hyperhidrosis, dry skin, swelling face, acquired lipodystrophy, angioneurotic edema, erythema multiforme, haemorrhagic stroke, rhabdomyolysis, toxic epidermal necrolysis, death."
175,INTELENCE,warnings and precautions,"severe skin reactions, fatal skin reactions, Stevens-Johnson syndrome, hypersensitivity reaction, toxic epidermal necrolysis, erythema multiforme, severe hypersensitivity, severe rash, rash with systemic symptoms, liver transaminase elevations, Drug Rash with Eosinophilia and Systemic Symptoms (DRESS), rash, constitutional findings, organ dysfunction, hepatic failure, Grade 3 rash, Grade 4 rash, fever, general malaise, fatigue, muscle aches, joint aches, blisters, oral lesions, conjunctivitis, facial edema, hepatitis, eosinophilia, angioedema, central obesity, dorsocervical fat enlargement (buffalo hump), peripheral wasting, facial wasting, breast enlargement, cushingoid appearance, immune reconstitution syndrome, inflammatory response, Mycobacterium avium infection, cytomegalovirus, Pneumocystis jiroveci pneumonia (PCP), tuberculosis, autoimmune disorders, Graves' disease, polymyositis, Guillain-Barre syndrome, death"
176,AMYVID,adverse reactions,"headache, musculoskeletal pain, blood pressure increased, hypertension, fatigue, nausea, injection site reaction, injection site haemorrhage, injection site irritation, injection site pain, anxiety, back pain, claustrophobia, dizziness, feeling cold, chills, insomnia, neck pain, infusion site rash, dysgeusia, pruritus, urticaria, flushing"
177,AMYVID,warnings and precautions,"image interpretation errors, false negatives, radiation risk, unintentional radiation exposure, errors, brain neuritic plaque density estimation errors, extensive brain atrophy, motion artifacts, increased risk of cancer"
178,ULESFIA,adverse reactions,"ocular irritation, application site irritation, application site anesthesia, hypoesthesia, pain, pruritus, erythema, pyoderma, application site dryness, application site excoriation, paraesthesia, application site dermatitis, excoriation, thermal burn, dandruff, rash, skin exfoliation"
179,ULESFIA,warnings and precautions,"gasping syndrome, neonatal toxicity, severe metabolic acidosis, gasping respirations, progressive hypotension, seizures, central nervous system depression, intraventricular hemorrhage, death, eye irritation, contact dermatitis"
180,OTEZLA,adverse reactions,"diarrhea, nausea, headache, upper respiratory tract infection, tension headache, vomiting, nasopharyngitis, abdominal pain upper, hypersensitivity, weight decrease, frequent bowel movement, gastroesophageal reflux disease, dyspepsia, decreased appetite, migraine, cough, rash, tension headache, fatigue, insomnia, back pain, depression, bronchitis, tooth abscess, folliculitis, sinus headache, severe worsening of psoriasis (rebound)"
181,OTEZLA,warnings and precautions,"depression, suicidal thoughts, mood changes, weight decrease, weight loss, drug interactions, loss of efficacy, depressed mood, suicidal ideation, suicidal behavior, attempted suicide, death"
182,ILARIS,adverse reactions,"nasopharyngitis, diarrhea, influenza, headache, nausea, abdominal pain, injection site reactions, infections, upper respiratory tract infections, serious infections, intra-abdominal abscess, vertigo, rhinitis, bronchitis, gastroenteritis, pharyngitis, weight increased, musculoskeletal pain, pneumonia, varicella, measles, sepsis, otitis media, sinusitis, adenovirus, lymph node abscess, tonsillitis, urinary tract infection, viral infection, hypersensitivity, decreased white blood cell counts, neutrophils, platelets, high ALT, high AST, elevated serum bilirubin"
183,ILARIS,warnings and precautions,"serious infections, upper respiratory tract infections, aspergillosis, atypical mycobacterial infections, cytomegalovirus, herpes zoster, tuberculosis, reactivation of latent tuberculosis, opportunistic infections, malignancies, hypersensitivity reactions, anaphylactic reactions, immunosuppression, macrophage activation syndrome (MAS), death"
184,NATAZIA,adverse reactions,"serious cardiovascular events, stroke, vascular events, liver disease, irregular uterine bleeding, nausea, breast tenderness, headache, headaches, migraine, breast pain, menstrual disorders, metrorrhagia, menorrhagia, menstruation irregular, genital hemorrhage, vaginal hemorrhage, dysfunctional uterine bleeding, abnormal withdrawal bleeding, uterine hemorrhage, vomiting, acne, mood changes, depression, mood swings, mood altered, depressed mood, dysthymic disorder, crying, increased weight, myocardial infarction, ruptured ovarian cyst, deep vein thrombosis, focal nodular hyperplasia of the liver, uterine leiomyoma, acute cholecystitis, chronic acalculous cholecystitis, venous thromboembolic events, arterial thromboembolic events, pulmonary emboli, cerebral thrombosis, hypertension, gallbladder disease, hepatitis, hypersensitivity, fluid retention, hypertriglyceridemia, dizziness, chloasma, angioedema, erythema nodosum, erythema multiforme, gastrointestinal symptoms, abdominal pain, vulvovaginal candidiasis"
185,NATAZIA,boxed warnings,serious cardiovascular events
186,NATAZIA,warnings and precautions,"thrombotic event, thromboembolism, venous thromboembolism, arterial thromboses, strokes, myocardial infarctions, cerebrovascular events, thrombotic strokes, hemorrhagic strokes, retinal vein thrombosis, jaundice, liver disease, hepatic adenomas, intra-abdominal hemorrhage, hepatocellular carcinoma, cholestasis, high blood pressure, hypertension, gallbladder disease, carbohydrate metabolic effects, lipid metabolic effects, decreased glucose tolerance, dyslipidemia, hypertriglyceridemia, pancreatitis, headache, migraine, breakthrough bleeding, spotting, bleeding irregularities, amenorrhea, oligomenorrhea, intracyclic bleeding, depression, hereditary angioedema, chloasma, death (due to rupture of hepatic adenomas causing intra-abdominal hemorrhage)."
187,DIFICID,adverse reactions,"nausea, vomiting, abdominal pain, gastrointestinal hemorrhage, anemia, neutropenia, abdominal distension, abdominal tenderness, dyspepsia, dysphagia, flatulence, intestinal obstruction, megacolon, increased blood alkaline phosphatase, decreased blood bicarbonate, increased hepatic enzymes, decreased platelet count, hyperglycemia, metabolic acidosis, drug eruption, pruritus, rash, hypersensitivity reactions, dyspnea, angioedema"
188,DIFICID,warnings and precautions,"angioedema, dyspnea, pruritus, rash, hypersensitivity reactions, drug-resistant bacteria"
189,ONFI,adverse reactions,"Somnolence, Sedation, Potentiation of Sedation, Withdrawal Symptoms, Serious Dermatological Reactions, Physical and Psychological Dependence, Suicidal Behavior and Ideation, Constipation, Pyrexia, Lethargy, Drooling, Ataxia, Aggression, Fatigue, Insomnia, Vomiting, Dysphagia, Irritability, Upper respiratory tract infection, Pneumonia, Urinary tract infection, Bronchitis, Decreased appetite, Increased appetite, Psychomotor hyperactivity, Dysarthria, Cough, Anemia, Eosinophilia, Leukopenia, Thrombocytopenia, Diplopia, Vision blurred, Abdominal distention, Hypothermia, Hepatic enzyme increased, Muscle spasms, Agitation, Anxiety, Apathy, Confusional state, Depression, Delirium, Delusion, Hallucination, Urinary retention, Aspiration, Respiratory depression, Rash, Urticaria, Angioedema, Facial and lip edema"
190,ONFI,warnings and precautions,"Somnolence, Sedation, CNS depression, Withdrawal symptoms, Serious Dermatological Reactions, Stevens-Johnson syndrome, Toxic epidermal necrolysis, Physical dependence, Psychological dependence, Suicidal Behavior, Suicidal Ideation, Convulsions, Psychosis, Hallucinations, Behavioral disorder, Tremor, Anxiety, Dysphoria, Insomnia, Depression, Mood changes, Thoughts about self-harm, Death (due to mention of suicides in drug-treated patients)."
191,TECFIDERA,adverse reactions,"anaphylaxis, angioedema, progressive multifocal leukoencephalopathy, lymphopenia, flushing, abdominal pain, diarrhea, nausea, vomiting, pruritus, rash, albuminuria (albumin urine present), erythema, dyspepsia, increased aspartate aminotransferase, eosinophilia"
192,TECFIDERA,warnings and precautions,"anaphylaxis, angioedema, difficulty breathing, urticaria, swelling of the throat and tongue, Progressive multifocal leukoencephalopathy (PML), death, lymphopenia, prolonged lymphopenia, progressive weakness, clumsiness of limbs, disturbance of vision, changes in thinking, memory and orientation, confusion, personality changes, flushing, warmth, redness, itching, burning sensation, serious infections"
193,DYSPORT,adverse reactions,"Distant Spread of Toxin Effect, Lack of Interchangeability between Botulinum Toxin Products, Spread of Effects from Toxin, Dysphagia, Breathing Difficulties, Facial Anatomy in the Treatment of Glabellar Lines, Pre-existing Neuromuscular Disorders, Human Albumin, Intradermal Immune Reaction, muscular weakness, dry mouth, injection site discomfort, fatigue, headache, neck pain, musculoskeletal pain, dysphonia, injection site pain, eye disorders, blurred vision, diplopia, reduced visual acuity, accommodation, nasopharyngitis, upper respiratory tract infection, eyelid edema, eyelid ptosis, sinusitis, nausea, urinary tract infection, dizziness, fall, depression, disturbance in attention, eyelid disorder, feeling abnormal, muscle atrophy, dyspnea, laboratory findings, blood glucose increase, electrocardiographic findings, heart rate reduction, blood present in urine, bronchitis, influenza, pharyngolaryngeal pain, cough, contact dermatitis, injection site swelling, injection site bruising, injection site reaction, numbness, erythema, tenderness, tingling, itching, stinging, warmth, irritation, tightness, swelling, pain in extremity, back pain, convulsion, syncope, hypoaesthesia, partial seizures, asthenia, injury, contusion, diarrhea, constipation, blood triglycerides increased, cough, hypertension, vertigo, photophobia, influenza-like illness, amyotrophy, burning sensation, facial paresis, hypoesthesia, erythema, excessive granulation tissue, gait disturbance, hypertonia, sensation of heaviness."
194,DYSPORT,boxed warnings,"asthenia, generalized muscle weakness, diplopia, blurred vision, ptosis, dysphagia, dysphonia, dysarthria, urinary incontinence, breathing difficulties, death"
195,DYSPORT,warnings and precautions,"respiratory difficulties, speech difficulties, swallowing difficulties, clinical effects of treatment exacerbation, transmission of Creutzfeldt-Jakob disease (CJD), asthenia, generalized muscle weakness, diplopia, blurred vision, ptosis, dysphagia, dysphonia, dysarthria, urinary incontinence, breathing difficulties, death, severe dysphagia, aspiration, critical loss of breathing capacity, respiratory failure, facial anatomy alterations, excessive weakness, muscle atrophy, marked facial asymmetry, inflammation at injection site, excessive dermatochalasis, deep dermal scarring, thick sebaceous skin, eyelid ptosis, peripheral motor neuropathic diseases, amyotrophic lateral sclerosis, neuromuscular junction disorders, myasthenia gravis, Lambert-Eaton syndrome, severe dysphagia, respiratory compromise, immune reaction, intradermal immune reaction"
196,ZYTIGA,adverse reactions,"Hypertension, Hypokalemia, Fluid Retention, Mineralocorticoid Excess, Adrenocortical Insufficiency, Hepatotoxicity, Fatigue, Joint Swelling, Discomfort, Edema, Hot Flush, Diarrhea, Vomiting, Cough, Dyspnea, Urinary Tract Infection, Contusion, Anemia, Elevated Alkaline Phosphatase, Hypertriglyceridemia, Lymphopenia, Hypercholesterolemia, Hyperglycemia, Elevated AST, Hypophosphatemia, Elevated ALT, Muscle Discomfort, Dyspepsia, Upper Respiratory Tract Infection, Urinary Frequency, Nocturia, Fractures, Arrhythmia, Chest Pain, Cardiac Failure, Pyrexia, Groin Pain, Constipation, Insomnia, Falls, Nasopharyngitis, Hematuria, Rash, Hypernatremia, Cardiorespiratory Arrest, Myocardial Ischemia, Myocardial Infarction, Non-infectious Pneumonitis, Myopathy, Rhabdomyolysis, Death"
197,ZYTIGA,warnings and precautions,"Mineralocorticoid excess, cardiovascular disease, LVEF < 50%, NYHA Class III heart failure, NYHA Class IV heart failure, hypertension, hypokalemia, fluid retention, adrenocortical insufficiency, hepatotoxicity, liver enzymes increase, drug interruption, dose modification, discontinuation, liver function, grade 3 hypertension, grade 4 hypertension, grade 3 hypokalemia, grade 4 hypokalemia, grade 3 edema, grade 4 edema, heart failure, recent myocardial infarction, ventricular arrhythmia, left ventricular ejection fraction <50%, New York Heart Association Class III heart failure, New York Heart Association Class IV heart failure, New York Heart Association Class II heart failure, adrenal insufficiency, prednisone interruption, concurrent infection, stress, ALT increase, AST increase, baseline ALT elevation, baseline AST elevation, liver test elevation, serum transaminases increase, bilirubin levels increase, moderate hepatic impairment, serum total bilirubin increase, AST elevation, ALT elevation, liver function tests abnormality, AST > 5* ULN, ALT > 5* ULN, bilirubin > 3* ULN, AST or ALT > 20* ULN, bilirubin > 10* ULN"
198,DUAVEE,adverse reactions,"Cardiovascular Disorders, Malignant Neoplasms, Gallbladder Disease, Hypertriglyceridemia, muscle spasms, nausea, diarrhea, dyspepsia, abdominal pain upper, oropharyngeal pain, dizziness, neck pain, hot flush, venous thromboembolism, deep venous thrombosis, pulmonary embolism, retinal vein thrombosis"
199,DUAVEE,boxed warnings,"endometrial cancer, cardiovascular disorders, probable dementia, endometrial hyperplasia, abnormal genital bleeding, stroke, deep vein thrombosis (DVT), hot flushes, osteoporosis, blood clots, unusual vaginal bleeding, cancer of the uterus, heart disease, heart attacks, strokes, dementia, breast cancer, cancer of the ovary, gallbladder problems, loss of vision, high blood pressure, increased fats in blood, liver problems, thyroid problems, fluid retention, low calcium, swelling of mouth or tongue, worsening of asthma, worsening of diabetes, worsening of epilepsy, migraines, porphyria, lupus, muscle spasms, nausea, diarrhea, upset stomach, abdominal pain, throat pain, dizziness, neck pain"
200,DUAVEE,warnings and precautions,"cardiovascular disorders, venous thromboembolism, pulmonary embolism, stroke, retinal vascular thrombosis, malignant neoplasms, endometrial cancer, breast cancer, ovarian cancer, gallbladder disease, loss of vision, severe hypertriglyceridemia, cholestatic jaundice, thyroid function, dementia, visual abnormalities, elevated blood pressure, hypertriglyceridemia, hepatic impairment, hypothyroidism, fluid retention, hypocalcemia, hereditary angioedema, exacerbation of asthma, exacerbation of diabetes mellitus, exacerbation of epilepsy, exacerbation of migraine, exacerbation of porphyria, exacerbation of systemic lupus erythematosus, hepatic hemangiomas, impaired glucose tolerance"
201,SAPHRIS,adverse reactions,"Dementia-Related Psychosis, Neuroleptic Malignant Syndrome, Tardive Dyskinesia, Metabolic Changes, Hypersensitivity Reactions, Application site reactions, oral ulcers, blisters, peeling/sloughing, inflammation, Orthostatic Hypotension, Syncope, Hemodynamic Effects, Leukopenia, Neutropenia, Agranulocytosis, QT Interval Prolongation, Hyperprolactinemia, Seizures, Cognitive Impairment, Motor Impairment, Body Temperature Regulation, Suicide, Dysphagia, akathisia, oral hypoesthesia, somnolence, dizziness, extrapyramidal symptoms, increased weight, dysgeusia, oral paresthesia, nausea, increased appetite, fatigue, constipation, dry mouth, salivary hypersecretion, stomach discomfort, vomiting, irritability, insomnia, hypertension, anxiety, depression, dysmenorrhea, oropharyngeal pain, nasal congestion, dyspnea, rash, tachycardia, heart rate increased, glossodynia, muscle strain, hyperinsulinemia, ALT increased, AST increased, dehydration, myalgia, parkinsonism, suicidal ideation, anger, edema peripheral, dystonia, oculogyration, dyskinesia, muscle rigidity, parkinsonism, tremor, extrapyramidal disorder, bradykinesia, oromandibular dystonia, muscle contractions involuntary, muscle twitching, musculoskeletal stiffness, protrusion tongue, resting tremor, diplopia, vision blurred, gastroesophageal reflux disease, photosensitivity reaction, enuresis, choking, oropharyngeal muscular dysfunction, hypoesthesia, death (as ""Suicide"" is mentioned)."
202,SAPHRIS,boxed warnings,"increased mortality, death"
203,SAPHRIS,warnings and precautions,"cerebrovascular adverse events, stroke, transient ischemic attack, Neuroleptic Malignant Syndrome, Tardive Dyskinesia, hyperglycemia, dyslipidemia, weight gain, anaphylaxis, angioedema, orthostatic hypotension, syncope, dizziness, tachycardia, bradycardia, Leukopenia, Neutropenia, Agranulocytosis, QT Prolongation, Seizures, Cognitive Impairment, Motor Impairment, suicide, death, hypersensitivity reactions, hypotension, swollen tongue, dyspnea, wheezing, rash, Hyperprolactinemia, Galactorrhea, amenorrhea, gynecomastia, impotence, Body Temperature Regulation, pyrexia, feeling hot, Dysphagia, aspiration pneumonia, myocardial infarction, unstable heart disease, sudden death, pneumonia, cardiac dysrhythmia, hyperpyrexia, muscle rigidity, altered mental status, autonomic instability, irregular pulse, blood pressure, diaphoresis, elevated creatine phosphokinase, myoglobinuria, rhabdomyolysis, acute renal failure, heart failure, systemic infection, extrapyramidal signs and symptoms, EPS, central anticholinergic toxicity, heat stroke, drug fever, primary central nervous system pathology, ketoacidosis, hyperosmolar coma, polydipsia, polyuria, polyphagia, weakness, fasting glucose abnormalities, diabetes mellitus, obesity, family history of diabetes, lipid alterations, total cholesterol elevations, LDL elevations, HDL reductions, fasting triglycerides elevations, Torsade de Pointes, delayed ventricular repolarization, bradycardia, hypokalemia, hypomagnesemia, congenital prolongation of the QT interval, hypothalamic GnRH suppression, pituitary gonadotropin secretion inhibition, reproductive function impairment, gonadal steroidogenesis inhibition, decreased bone density, hypogonadism, conditions that lower the seizure threshold, somnolence, sedation, hypersomnia, mental alertness impairment, hazardous machinery operation impairment, motor vehicle operation impairment, anticholinergic activity, dehydration, esophageal dysmotility, aspiration."
204,DUREZOL,adverse reactions,"elevated intraocular pressure, optic nerve damage, visual acuity defects, field defects, posterior subcapsular cataract formation, secondary ocular infection, herpes simplex, perforation of the globe, corneal thinning, scleral thinning, corneal edema, ciliary hyperemia, conjunctival hyperemia, eye pain, photophobia, posterior capsule opacification, anterior chamber cells, anterior chamber flare, conjunctival edema, blepharitis, reduced visual acuity, punctate keratitis, eye inflammation, iritis, application site discomfort, application site irritation, corneal pigmentation, corneal striae, episcleritis, eye pruritis, eyelid irritation, eyelid crusting, foreign body sensation, increased lacrimation, macular edema, sclera hyperemia, uveitis, blurred vision, headache, increased IOP, limbal hyperemia, dry eye, iridocyclitis"
205,DUREZOL,warnings and precautions,"Intraocular pressure increase, glaucoma, damage to the optic nerve, defects in visual acuity, defects in fields of vision, cataracts, posterior subcapsular cataract formation, delayed healing, bleb formation, corneal or scleral thinning, corneal or scleral perforations, bacterial infections, secondary ocular infections, acute purulent conditions, viral infections, exacerbation of viral infections, herpes simplex, fungal infections, corneal fungal infections, corneal ulceration, persistent corneal ulceration"
206,ZYDELIG,adverse reactions,"Hepatotoxicity, Severe Diarrhea, Colitis, Pneumonitis, Intestinal Perforation, Severe Cutaneous Reactions, Anaphylaxis, Neutropenia, Diarrhea, Pyrexia, Fatigue, Nausea, Cough, Pneumonia, Abdominal Pain, Chills, Rash, Hypertriglyceridemia, Hyperglycemia, ALT elevations, AST elevations, Sepsis, Febrile Neutropenia, Vomiting, Gastroesophageal Reflux Disease, Stomatitis, Headache, Pain, Nasal Congestion, Bronchitis, Sinusitis, Urinary Tract Infection, Arthralgia, Lymphocyte Count Decreased, Lymphocyte Count Increased, GGT Increased, Hypoglycemia, Hyponatremia, Asthenia, Peripheral Edema, Upper Respiratory Tract Infection, Dyspnea, Night Sweats, Decreased Appetite, Insomnia, Hemoglobin Decreased, Platelets Decreased"
207,ZYDELIG,boxed warnings,"hepatic toxicity, severe diarrhea, colitis, pneumonitis, intestinal perforation, death"
208,ZYDELIG,warnings and precautions,"severe cutaneous reactions, anaphylaxis, neutropenia, embryo-fetal toxicity, hepatotoxicity, death, elevations in ALT, elevations in AST, severe diarrhea, colitis, pneumonitis, intestinal perforation, toxic epidermal necrolysis (TEN), dermatitis exfoliative, rash, rash erythematous, rash generalized, rash macular, rash maculo-papular, rash papular, rash pruritic, exfoliative rash, skin disorder, allergic reactions, Grade 3 neutropenia, Grade 4 neutropenia, teratogenic effects"
209,KALBITOR,adverse reactions,"Hypersensitivity reactions, anaphylaxis, headache, nausea, diarrhea, pyrexia, injection site reactions, nasopharyngitis, fatigue, upper respiratory tract infection, vomiting, pruritus, upper abdominal pain, erythema, pain, irritation, urticaria, bruising, anti-ecallantide antibodies, neutralizing antibodies, anti-ecallantide IgE antibodies, anti-P. pastoris IgE antibodies"
210,KALBITOR,boxed warnings,"anaphylaxis, hypersensitivity reactions, hereditary angioedema"
211,KALBITOR,warnings and precautions,"anaphylaxis, hypersensitivity reactions, chest discomfort, flushing, pharyngeal edema, pruritus, rhinorrhea, sneezing, nasal congestion, throat irritation, urticaria, wheezing, hypotension, rash"
212,ADCETRIS,adverse reactions,"Peripheral Neuropathy, Anaphylaxis, Infusion Reactions, Hematologic Toxicities, Serious Infections, Opportunistic Infections, Tumor Lysis Syndrome, Severe Renal Impairment, Moderate Hepatic Impairment, Severe Hepatic Impairment, Hepatotoxicity, Progressive Multifocal Leukoencephalopathy, Pulmonary Toxicity, Serious Dermatologic Reactions, Neutropenia, Peripheral Sensory Neuropathy, Fatigue, Nausea, Anemia, Upper Respiratory Tract Infection, Diarrhea, Pyrexia, Rash, Thrombocytopenia, Cough, Vomiting, Peripheral Motor Neuropathy, Lymphadenopathy, Headache, Dizziness, Chills, Pain, Edema Peripheral, Constipation, Pruritus, Alopecia, Night Sweats, Dry Skin, Dyspnea, Oropharyngeal Pain, Arthralgia, Myalgia, Back Pain, Pain in Extremity, Muscle Spasms, Insomnia, Anxiety, Decreased Appetite, Weight Decreased, Febrile Neutropenia, Hyperglycemia, Pancreatitis, Noninfectious Pulmonary Toxicity, Pneumonitis, Interstitial Lung Disease, Acute Respiratory Distress Syndrome (ARDS), Toxic Epidermal Necrolysis, Death"
213,ADCETRIS,boxed warnings,"Progressive Multifocal Leukoencephalopathy (PML), JC virus infection, death"
214,ADCETRIS,warnings and precautions,"Peripheral neuropathy, neuropathy, hypoesthesia, hyperesthesia, paresthesia, discomfort, burning sensation, neuropathic pain, weakness, anaphylaxis, infusion reactions, hematologic toxicities, neutropenia, thrombocytopenia, anemia, febrile neutropenia, serious infections, opportunistic infections, pneumonia, bacteremia, sepsis, septic shock, death, tumor lysis syndrome, hepatotoxicity, hepatocellular injury, elevations of transaminases, elevated bilirubin, progressive multifocal leukoencephalopathy (PML), pulmonary toxicity, pneumonitis, interstitial lung disease, acute respiratory distress syndrome (ARDS), cough, dyspnea, serious dermatologic reactions, Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), embryo-fetal toxicity, fetal harm, decreased embryo viability, fetal malformations."
215,BESIVANCE,adverse reactions,"conjunctival redness, blurred vision, eye pain, eye irritation, eye pruritus, headache"
216,BESIVANCE,warnings and precautions,"Growth of Resistant Organisms with Prolonged Use, overgrowth of non-susceptible organisms, fungi, super-infection, bacterial conjunctivitis"
217,CLEVIPREX,adverse reactions,"hypotension, reflex tachycardia, headache, nausea, vomiting, acute renal failure, atrial fibrillation, myocardial infarction, cardiac arrest, syncope, dyspnea, increased blood triglycerides, ileus, hypersensitivity, decreased oxygen saturation (possible pulmonary shunting)"
218,CLEVIPREX,warnings and precautions,"hypotension, reflex tachycardia, negative inotropic effects, exacerbation of heart failure, rebound hypertension, lipid metabolism disorders"
219,XTANDI,adverse reactions,"Seizure, asthenia, fatigue, back pain, decreased appetite, constipation, arthralgia, diarrhea, hot flush, upper respiratory tract infection, peripheral edema, dyspnea, musculoskeletal pain, weight decreased, headache, hypertension, dizziness, vertigo, muscular weakness, musculoskeletal stiffness, spinal cord compression, cauda equina syndrome, paresthesia, mental impairment disorders, hypoesthesia, lower respiratory tract infection, lung infection, insomnia, anxiety, hematuria, pollakiuria, fall, non-pathologic fractures, pruritus, dry skin, epistaxis, dysgeusia, restless legs syndrome, gynecomastia, neutropenia, thrombocytopenia, elevations in ALT, elevations in bilirubin, infections, sepsis, fall-related injuries, joint injuries, hematomas, hypertensive crisis, death"
220,XTANDI,warnings and precautions,"seizure, death"
221,BOSULIF,adverse reactions,"Gastrointestinal toxicity, Myelosuppression, Hepatic toxicity, Fluid retention, Renal toxicity, Diarrhea, Nausea, Thrombocytopenia, Vomiting, Abdominal pain, Rash, Anemia, Pyrexia, Fatigue, Anaphylactic shock, Increased alanine aminotransferase, Headache, Cough, Increased aspartate aminotransferase, Neutropenia, Edema, Arthralgia, Decreased appetite, Respiratory tract infection, Nasopharyngitis, Back pain, Asthenia, Pruritus, Dizziness, Dyspnea, QTcF interval prolongation, Platelet Count Low, Absolute Neutrophil Count Low, Hemoglobin Low, SGPT/ALT increased, SGOT/AST increased, Lipase increased, Phosphorus Low, Total Bilirubin increased, Febrile neutropenia, Pericardial effusion, Pericarditis, Tinnitus, Gastritis, Acute pancreatitis, Gastrointestinal hemorrhage, Chest pain, Pain, Hepatotoxicity, Abnormal hepatic function, Liver injury, Drug hypersensitivity, Pneumonia, Influenza, Bronchitis, Electrocardiogram QT prolonged, Increased blood creatine phosphokinase, Increased blood creatinine, Hyperkalemia, Dehydration, Myalgia, Dysgeusia, Acute renal failure, Renal failure, Pleural effusion, Acute pulmonary edema, Respiratory failure, Pulmonary hypertension, Urticaria, Acne, Erythema multiforme, Exfoliative rash, Drug eruption"
222,BOSULIF,warnings and precautions,"Gastrointestinal Toxicity, Diarrhea, Nausea, Vomiting, Abdominal Pain, Myelosuppression, Thrombocytopenia, Anemia, Neutropenia, Hepatic Toxicity, Drug Induced Liver Injury, ALT Elevation, AST Elevation, Transaminase Elevations, Fluid Retention, Pericardial Effusion, Pleural Effusion, Pulmonary Edema, Peripheral Edema, Renal Toxicity, Decline in eGFR, Kidney Failure, Embryofetal Toxicity, Fetal Harm"
223,CARBAGLU,adverse reactions,"Infections, vomiting, abdominal pain, pyrexia, tonsillitis, anemia, ear infection, diarrhea, nasopharyngitis, headache, dysgeusia, asthenia, hyperhidrosis, influenza, pneumonia, hemoglobin decreased, weight decreased, anorexia, somnolence, rash"
224,CARBAGLU,warnings and precautions,"Hyperammonemia, injury to the brain, brain injury/damage, death"
225,SIMPONI,adverse reactions,"serious infections, malignancies, upper respiratory tract infection, viral infection, bronchitis, hypertension, rash, sepsis, pneumonia, cellulitis, abscess, opportunistic infections, tuberculosis, invasive fungal infections, liver enzyme elevations, autoimmune disorders, autoantibodies, lupus-like syndrome, administration reactions, immunogenicity, antibodies to SIMPONI ARIA, neutralizing antibodies, infections and infestations, bacterial infections, vascular disorders, skin and subcutaneous disorders, general disorders and administration site conditions, pyrexia, blood and lymphatic disorders, leukopenia, superficial fungal infection, sinusitis, lower respiratory tract infection, pyelonephritis, investigations, alanine aminotransferase increased, aspartate aminotransferase increased, neutrophil count decreased, nervous system disorders, dizziness, paresthesia, gastrointestinal disorders, constipation, neoplasm benign and malignant, melanoma, immune system disorders, serious systemic hypersensitivity reactions, anaphylactic reaction, sarcoidosis, respiratory, thoracic and mediastinal disorders, interstitial lung disease, skin and subcutaneous tissue disorders, skin exfoliation, bullous skin reactions"
226,SIMPONI,boxed warnings,"serious infections, hospitalization, death, tuberculosis (TB), bacterial sepsis, invasive fungal infections, histoplasmosis, opportunistic infections, sepsis, latent TB, active TB, lymphoma, malignancies, reactivation of latent tuberculosis, disseminated disease, extrapulmonary disease, invasive fungal infections, coccidioidomycosis, candidiasis, aspergillosis, blastomycosis, pneumocystosis, bacterial infections, viral infections, Legionella, Listeria, chronic infection, recurrent infection"
227,SIMPONI,warnings and precautions,"serious infections, active infection, invasive fungal infections, systemic illness, mycoses, Hepatitis B reactivation, HBV carriers, Malignancies, lymphoma, Heart failure, worsening heart failure, new onset heart failure, Demyelinating disease, exacerbation of demyelinating disease, new onset of demyelinating disease, Hypersensitivity reactions, anaphylaxis, opportunistic infections, bacterial infections, mycobacterial infections, viral infections, parasitic infections, aspergillosis, blastomycosis, candidiasis, coccidioidomycosis, histoplasmosis, legionellosis, listeriosis, pneumocystosis, tuberculosis, sepsis, Tuberculosis reactivation, new tuberculosis infections, Hepatitis B Virus Reactivation, Malignancies in Pediatric Patients, Hodgkin's lymphoma, non-Hodgkin's lymphoma, Malignancies in Adult Patients, non-melanoma skin cancer (NMSC), lymphoma, acute leukemia, chronic leukemia, hepatosplenic T-cell lymphoma (HSTCL), Melanoma, Merkel cell carcinoma, Congestive Heart Failure, CHF exacerbations, Demyelinating Disorders, multiple sclerosis (MS), peripheral demyelinating disorders, Guillain-Barre syndrome, central demyelination, optic neuritis, peripheral demyelinating polyneuropathy, Hematologic Cytopenias, pancytopenia, leukopenia, neutropenia, aplastic anemia, thrombocytopenia, Vaccinations/Therapeutic Infectious Agents, Live Vaccines, disseminated infections, Therapeutic Infectious Agents, serious systemic hypersensitivity reactions, death (if we consider the mention of fatal events in the context of malignancies and HBV reactivation)."
228,BENLYSTA,adverse reactions,"Mortality, Serious Infections, Malignancy, Hypersensitivity Reactions, Anaphylaxis, Infusion Reactions, Depression, Nausea, Diarrhea, Pyrexia, Nasopharyngitis, Bronchitis, Insomnia, Pain in extremity, Migraine, Pharyngitis, Cystitis, Leukopenia, Gastroenteritis viral, Fatal anaphylaxis, Death"
229,BENLYSTA,warnings and precautions,"mortality, deaths, serious infections, fatal infections, immunosuppressive agents, Progressive Multifocal Leukoencephalopathy (PML), JC virus-associated PML, neurological deficits, hypersensitivity reactions, anaphylaxis, death, depression, suicidality, suicidal thoughts, mood changes, live vaccines, malignancies, non-melanoma skin cancers, acute hypersensitivity reactions, rash, nausea, fatigue, myalgia, headache, facial edema, hypersensitivity, infusion reactions, bradycardia, urticaria, hypotension, psychiatric events, insomnia, anxiety, serious psychiatric events, serious depression, suicides, immunizations, biologic therapies, intravenous cyclophosphamide, upper respiratory tract infection, urinary tract infection, nasopharyngitis, sinusitis, bronchitis, influenza, pneumonia, cellulitis, infection, cardiovascular disease, suicide, angioedema, pruritus, dyspnea, skin reactions, secondary transmission of infection, new immunizations, death"
230,TOVIAZ,adverse reactions,"dry mouth, constipation, dyspepsia, nausea, abdominal pain upper, urinary tract infection, upper respiratory tract infection, dry eyes, dysuria, urinary retention, cough, dry throat, edema peripheral, back pain, insomnia, ALT increased, GGT increased, rash, blurred vision, palpitations, hypersensitivity reactions, angioedema with airway obstruction, face edema, dizziness, headache, somnolence, urticaria, pruritus, angina, chest pain, gastroenteritis, QT prolongation on ECG, diverticulitis, irritable bowel syndrome, electrocardiogram QT corrected interval prolongation"
231,TOVIAZ,warnings and precautions,"Angioedema, urinary retention, severe constipation, narrow-angle glaucoma, somnolence, headache, dizziness, life-threatening upper airway swelling, death"
232,ENTEREG,adverse reactions,dyspepsia
233,ENTEREG,boxed warnings,myocardial infarction
234,ENTEREG,warnings and precautions,"myocardial infarctions, abdominal pain, nausea, vomiting, diarrhea, serious adverse reactions, dose-related serious adverse reactions, death"
235,VIZAMYL,adverse reactions,"flushing, headache, increased blood pressure, nausea, dizziness, serious hypersensitivity reaction, dyspnea, chest pressure, death"
236,VIZAMYL,warnings and precautions,"hypersensitivity reactions, flushing, dyspnea, image interpretation errors, false positives, radiation risk, cancer, unintentional radiation exposure"
237,AMPYRA,adverse reactions,"Seizures, Anaphylaxis, Urinary Tract Infections, insomnia, dizziness, headache, nausea, asthenia, back pain, balance disorder, multiple sclerosis relapse, paresthesia, nasopharyngitis, constipation, dyspepsia, pharyngolaryngeal pain, confusional state"
238,AMPYRA,warnings and precautions,"seizures, anaphylaxis, renal impairment, urinary tract infections, respiratory compromise, urticaria, angioedema"
